rfhg_43127.1

Basic information about the TSS

---

TSS ID: rfhg_43127.1 TSS ID(Version3): hg_35652.1 hg_35653.1 hg_35650.1 hg_35654.1 hg_35651.1 Species: human Chr: chr3		Start: 19947060 End: 19947389 Strand: +
Source datasets	FANTOM5|EPD|PRJNA597322|PRJNA401781|PRJNA548673|PRJNA615891 |PRJNA4843412|DRA013844|PRJDB5282
Protocol	CAGE|TSS_database|STRIPE-seq|RAMPAGE|ReCappable-seq |SLIC_CAGE|oligo_capping|NETCAGE|TIF-seq2|C1CAGE
TSS cluster detected*	13

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3401014,EH38E2184092)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000273047.9:0 ENST00000443878.1:0 ENST00000412966.5:0 AF464088:0 AK312618:0 GeneID: 5868 HGNC/MGI_ID: HGNC:9783 UniProt_ID: A0A024R2K1 C9J3X8 F8WCY6 Nearer transcript ids and distances: BC018288:8 ENST00000446547.5:10 AK309287:10 ENST00000422242.1:16 AK295992:16 ENST00000476544.1:21 BC001267:61 view more...

Gene_name: RAB5A, member RAS oncogene family Gene_symbol: RAB5A Gene_synonyms: Gene_source: HGNC:9783

TATA-Box annotation

---

Distance to TSS:	127
Nearest PromoterID:	NM_004162
Entrez ID:	5868
Nearest Unigene:	Hs.475663
Nearest Refseq:	NM_004162
Nearest Ensembl:	ENSG00000144566
Gene Name:	RAB5A, member RAS oncogene family
Gene Alias:	RAB5
Gene Type:	protein-coding
CpG%:	0.109422
GC%:	0.690909
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAB5A p2@RAB5A p3@RAB5A p4@RAB5A p5@RAB5A p6@RAB5A p8@RAB5A p9@RAB5A
Sample		p1@RAB5A	p2@RAB5A	p3@RAB5A	p4@RAB5A	p5@RAB5A	p6@RAB5A	p8@RAB5A	p9@RAB5A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	11.30	10.91	5.45	2.14	0.58	2.34	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	14.16	8.30	3.84	1.82	1.21	1.21	0.61	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	14.08	12.54	4.63	2.70	1.93	1.93	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	12.06	7.48	3.33	1.66	0.21	2.29	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	18.22	7.87	6.30	2.02	0.67	1.80	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	12.99	6.40	4.07	1.74	1.16	1.16	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	15.03	8.50	5.88	2.18	0.65	1.53	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	14.05	7.27	5.57	2.91	1.21	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	11.97	7.91	6.63	2.56	0.64	1.07	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	19.13	8.11	3.48	2.90	3.48	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	21.83	10.11	6.06	1.21	1.62	4.04	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.14	19.92	8.54	4.47	2.03	3.25	1.22	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	9.99	3.55	3.55	2.58	0.48	0.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	9.17	3.61	4.96	2.71	0.15	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	7.90	3.29	3.51	1.54	0.22	0.22	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	8.05	3.02	3.52	2.01	0.50	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	7.64	1.97	3.06	2.84	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	6.75	2.11	2.11	3.80	0.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.80	2.67	4.80	1.60	0.53	0.53	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	7.07	3.61	4.81	3.46	0.30	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	11.09	4.54	5.75	1.87	1.07	0.00	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.81	3.63	4.83	3.97	0.17	0.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	9.05	4.27	4.91	2.33	0.39	0.00	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	9.46	2.43	1.94	2.43	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	9.80	3.61	4.90	2.06	1.03	1.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.13	3.80	5.70	2.53	0.95	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	11.54	2.75	7.14	1.10	0.00	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	11.08	7.07	6.37	3.54	0.47	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	7.75	3.55	4.36	3.07	0.32	0.48	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.05	4.52	3.98	3.62	0.90	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	7.12	4.61	1.47	2.93	0.42	0.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.86	3.52	1.95	2.15	0.39	0.39	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.39	3.80	4.85	2.74	0.42	0.21	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	9.57	3.79	6.60	3.63	0.49	0.16	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.23	5.42	2.62	2.80	0.56	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	8.81	2.68	3.45	2.49	0.19	0.00	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	5.93	4.50	4.29	2.45	1.02	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.66	4.03	5.64	4.03	0.60	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	9.18	4.59	3.78	5.40	0.27	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	6.72	4.08	4.32	2.40	0.24	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	6.59	4.23	3.29	2.59	0.47	0.71	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	9.81	4.54	4.83	3.22	0.44	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.01	4.43	2.53	3.59	0.21	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.69	7.69	5.07	4.37	0.17	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.24	5.22	4.02	4.62	0.60	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	6.05	3.49	4.65	3.49	0.47	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	10.08	3.12	4.08	3.36	0.96	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	5.07	3.28	4.47	3.58	0.00	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	10.53	4.07	4.79	5.03	0.72	0.96	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	7.68	5.66	4.65	4.04	0.40	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.20	5.33	3.07	6.97	0.20	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	5.78	6.00	3.11	4.67	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	27.98	55.97	0.00	13.99	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	4.97	3.19	5.68	2.84	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	6.96	4.97	3.98	3.98	0.33	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	27.68	5.87	15.94	3.36	2.52	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	15.61	3.21	7.81	3.21	0.46	0.92	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	2.27	5.51	3.57	5.51	0.00	0.97	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	2.89	4.50	1.61	4.50	0.64	0.00	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	16.66	4.40	9.43	6.92	0.63	0.63	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.76	4.23	2.12	5.64	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.93	3.36	3.93	2.80	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	25.48	3.98	13.53	6.37	1.59	0.80	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	15.63	2.38	7.47	3.06	1.02	1.02	0.34	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.22	3.25	0.97	5.20	0.32	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	5.32	4.61	1.77	3.55	0.00	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	71.08	7.90	39.49	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	11.21	2.44	3.41	2.93	0.49	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	6.45	2.98	4.46	5.45	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	8.44	3.28	6.10	4.69	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.26	4.64	8.61	3.64	1.32	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	7.11	1.86	1.24	5.26	0.31	0.31	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.95	3.97	2.45	7.34	0.00	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	6.81	6.65	1.74	4.43	1.27	1.11	0.63	0.00
Adipocyte - breast, donor2	11327-117E4	10.75	7.06	6.42	7.54	0.96	0.32	0.32	0.00
Adipocyte - omental, donor1	11473-119C6	12.72	11.45	5.34	6.87	1.15	0.38	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	14.95	10.46	5.23	6.73	0.00	1.49	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	12.39	7.70	6.36	5.69	1.00	0.67	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	12.12	8.29	3.19	8.29	0.64	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	2.20	3.30	1.10	0.00	1.10	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	4.97	4.06	3.16	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	9.73	4.69	4.34	2.61	0.17	0.52	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	19.36	13.49	5.87	5.87	0.78	0.78	0.59	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	19.05	7.72	8.24	5.66	0.26	0.26	0.77	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	17.56	2.79	5.30	4.74	0.84	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	23.51	5.29	7.64	6.47	0.59	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	20.83	14.16	8.93	6.76	1.05	0.40	0.56	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	22.59	6.78	6.78	3.55	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	18.13	4.80	6.93	4.27	2.13	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	16.69	6.12	6.12	6.12	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	12.48	7.07	7.90	8.32	0.83	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	12.81	6.53	7.03	2.26	0.25	0.00	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	8.18	4.91	4.58	0.33	0.65	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	14.92	5.78	7.00	2.44	0.61	0.00	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	11.71	6.85	4.20	2.87	0.22	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.94	1.79	2.51	1.08	0.36	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	0.00	2.40	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.33	3.42	2.52	2.88	0.54	0.18	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.22	3.08	3.08	3.70	1.64	0.41	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	19.91	6.64	7.90	8.47	0.46	0.11	0.11	0.00
Anulus Pulposus Cell, donor2	11463-119B5	17.63	6.86	5.14	7.10	0.73	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	3.59	4.04	2.70	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	13.02	6.08	3.91	7.81	0.43	0.43	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	2.14	4.28	4.28	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.26	6.58	4.48	6.58	0.60	0.60	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	3.79	10.12	5.06	6.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	11.22	3.96	1.98	4.62	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	11.70	5.52	4.87	4.55	0.65	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	11.17	4.85	7.28	7.28	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	7.13	5.94	2.97	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.20	4.52	5.65	7.16	0.75	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	9.43	2.90	5.81	5.81	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	10.03	2.51	3.76	2.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	11.37	6.92	8.24	6.75	0.33	0.16	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	1.36	2.73	8.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.88	4.67	3.32	4.52	1.21	0.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	13.93	10.18	4.29	6.43	1.07	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	10.96	7.56	4.53	4.35	0.57	0.76	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	8.55	5.08	4.81	5.88	0.53	0.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	3.90	7.80	3.90	3.90	0.00	0.98	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	8.96	6.97	4.31	4.98	1.00	0.33	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	2.40	3.60	6.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	13.38	7.03	5.15	6.52	1.03	0.34	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	8.39	0.00	8.39	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.22	7.77	4.37	5.34	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	6.83	6.07	4.93	0.38	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	7.27	3.63	3.63	2.42	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.26	7.98	7.98	9.12	0.57	1.14	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	10.69	3.85	6.84	6.84	0.86	0.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	7.23	5.16	4.90	3.61	0.52	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.26	4.69	5.63	6.10	0.47	0.47	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	11.90	3.22	3.86	5.14	0.64	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	4.28	3.57	4.99	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.70	5.26	5.26	5.85	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.44	5.42	4.82	3.91	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	4.75	8.32	5.94	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.19	5.59	5.59	4.07	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	4.84	7.13	6.62	1.02	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	6.35	4.45	2.54	3.18	1.27	1.27	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	6.47	6.04	6.04	5.18	0.43	0.86	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.07	6.56	5.08	4.23	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	6.96	4.35	2.90	3.77	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	5.67	4.72	4.72	4.72	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.38	5.09	4.07	5.42	0.68	0.34	0.17	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	0.00	2.32	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	21.13	2.11	2.11	4.23	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	8.15	6.43	6.22	5.36	0.21	0.86	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	3.61	3.61	3.01	3.61	1.80	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	10.21	8.02	6.56	9.48	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	13.33	7.59	5.52	5.52	0.92	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	2.55	2.55	15.30	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.34	8.14	3.56	4.07	1.02	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	13.01	10.94	6.19	7.23	0.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.96	6.43	3.37	3.37	0.31	0.31	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.52	7.17	5.26	13.38	0.96	1.43	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.76	6.87	4.21	7.98	0.89	0.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	3.05	3.05	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	3.32	6.09	6.09	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.12	7.68	3.71	4.50	0.53	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	7.27	7.27	1.45	5.82	0.36	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	12.28	2.95	3.07	2.21	0.49	0.00	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	8.22	1.88	2.23	2.40	0.34	0.34	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	10.70	0.63	1.68	0.84	0.42	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	35.21	10.81	6.62	8.02	0.35	0.35	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	16.82	15.37	6.96	5.66	1.29	1.62	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	23.57	16.71	10.89	9.25	1.64	0.45	0.15	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	23.97	9.40	12.27	6.31	0.92	0.46	0.11	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	20.92	8.77	11.28	5.51	0.25	0.88	0.25	0.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.09	6.49	9.56	6.03	0.68	0.46	0.23	0.00
Basophils, donor1	12241-129G9	15.69	30.34	14.91	9.68	2.35	0.78	0.52	0.26
Basophils, donor2	12242-129H1	17.32	29.22	19.12	7.94	2.53	3.25	0.36	0.72
Basophils, donor3	12243-129H2	11.61	32.49	6.61	8.38	2.65	1.18	0.29	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	7.98	3.23	4.53	2.16	0.65	0.00	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	1.83	2.74	1.37	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	7.17	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	5.02	1.88	1.88	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	6.65	1.46	1.66	1.25	0.21	0.62	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.36	3.45	4.61	3.91	0.69	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	10.26	8.46	3.96	5.40	0.90	0.18	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	13.50	3.92	3.61	1.85	0.31	0.21	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	14.21	9.08	4.66	6.29	1.63	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	8.95	14.71	2.56	6.08	0.96	0.64	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	39.45	12.40	9.58	2.25	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	22.09	43.99	13.73	15.40	2.23	2.60	0.00	0.56
CD14+ Monocytes, donor3	11381-118B4	20.64	39.08	13.83	11.64	2.85	2.63	0.44	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	17.27	18.11	8.49	13.87	2.26	1.13	1.13	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.54	25.02	6.44	11.75	1.52	0.38	1.90	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.98	18.41	9.20	17.09	1.64	0.00	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	20.24	31.95	12.86	19.51	3.18	3.32	0.87	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	15.09	43.45	12.07	22.03	3.62	0.60	0.60	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	13.98	44.77	6.87	19.66	4.74	2.37	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	24.61	47.88	13.22	22.10	4.02	1.51	0.84	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	22.36	60.72	16.56	17.66	3.86	1.93	0.83	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.08	81.57	8.93	17.36	5.95	2.48	1.49	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	31.33	43.27	9.99	15.27	3.33	3.72	0.00	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	14.78	43.98	10.15	19.76	4.27	0.53	0.71	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.10	77.48	6.09	21.76	8.27	1.74	0.65	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	28.56	50.34	13.11	17.79	3.28	2.11	0.23	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	26.40	74.98	10.03	25.87	6.86	1.58	0.53	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	83.20	9.98	22.19	3.33	3.33	0.00	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.65	47.30	11.60	20.23	4.61	1.78	0.89	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	19.76	59.47	8.98	20.75	3.79	0.60	0.40	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.24	73.70	7.70	20.40	7.70	3.12	0.62	2.08
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	34.09	77.56	19.45	20.82	9.38	3.89	0.46	1.60
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.74	76.00	10.63	18.77	8.14	0.45	0.23	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.33	76.38	6.55	18.33	6.11	3.06	0.44	3.06
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	31.74	34.16	9.41	21.52	2.96	1.34	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	16.22	52.51	9.07	20.76	4.01	0.70	0.70	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	18.94	50.92	7.15	17.67	2.95	0.84	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	39.87	82.85	19.66	23.51	7.16	4.04	1.10	1.10
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	40.16	84.90	22.90	23.60	5.28	2.11	1.41	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.94	97.84	11.41	22.81	9.21	1.32	1.32	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.03	29.82	13.25	11.86	3.31	2.62	0.52	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.58	33.82	14.50	12.64	2.97	1.86	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	15.30	56.69	7.11	15.74	4.53	1.94	0.43	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	27.44	58.97	12.28	21.29	5.73	2.87	0.41	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.72	82.52	12.98	22.48	7.65	2.09	0.46	1.85
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	16.01	104.16	7.66	14.15	8.35	2.09	2.09	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	8.94	10.68	3.92	13.51	0.87	0.00	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.55	13.86	2.08	12.01	1.15	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	8.23	9.96	2.17	9.75	2.17	0.22	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	10.74	14.48	3.11	13.39	0.93	0.31	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.13	12.05	2.62	15.02	1.57	0.35	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	18.28	20.29	8.03	17.17	1.34	1.11	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	6.89	10.97	5.87	7.66	0.77	0.26	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	8.34	11.64	4.61	7.68	1.98	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	9.26	10.53	4.63	12.84	0.84	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	20.32	8.13	6.10	2.03	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	16.27	4.75	12.20	6.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	2.07	6.21	1.04	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	18.66	5.86	13.86	2.67	1.60	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	24.66	3.22	11.79	5.36	2.68	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	21.76	4.21	5.62	6.32	1.40	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	18.04	3.92	9.41	3.14	2.35	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	14.50	5.27	5.27	2.64	2.64	0.00	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	38.63	28.77	28.77	5.75	0.00	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	55.86	10.88	30.47	6.53	3.63	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	38.87	25.24	21.20	8.08	2.02	2.02	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	45.25	21.82	27.48	2.02	2.83	1.21	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	30.76	14.38	21.17	2.80	2.80	2.80	1.20	0.00
CD34+ Progenitors, donor1	11545-120B6	12.05	16.06	10.04	13.05	3.01	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	15.73	59.55	27.53	13.48	2.81	4.49	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	9.02	8.64	3.38	7.89	1.13	1.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.05	7.67	4.06	6.76	0.68	0.23	0.00	0.23
CD4+ T Cells, donor1	11225-116C1	92.48	22.14	34.63	7.50	5.00	2.50	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	61.85	22.05	33.68	3.06	0.61	3.67	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	46.05	28.67	26.53	5.49	1.83	3.35	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	8.93	9.19	8.93	8.17	1.79	1.02	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	15.72	9.43	8.53	4.94	1.12	1.12	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	16.10	8.62	9.77	6.32	0.86	1.15	0.57	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	28.92	10.90	22.76	5.69	3.32	1.90	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	35.82	11.94	13.34	3.51	3.51	4.21	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	32.96	3.30	13.18	9.89	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	7.95	9.83	6.94	10.55	1.30	1.01	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	10.34	11.02	4.91	9.49	2.20	0.68	0.34	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	8.87	9.35	6.93	8.06	1.77	1.61	0.16	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	19.73	8.52	21.52	4.93	2.69	1.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.82	10.48	11.53	8.04	1.40	2.10	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	22.44	14.08	16.72	7.48	0.00	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	13.07	15.60	5.48	8.43	2.11	0.84	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	7.27	16.41	4.16	8.31	2.08	1.45	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	7.35	15.04	7.02	9.36	0.67	1.34	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	31.00	8.70	11.69	4.89	2.45	0.82	0.82	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	17.69	12.33	6.97	5.36	2.14	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	10.76	3.59	8.97	3.59	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	8.34	14.09	9.27	11.87	2.04	1.48	0.37	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	8.01	9.96	4.77	8.45	0.65	1.08	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.25	11.56	8.20	6.51	1.47	3.36	0.63	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	19.21	15.17	12.13	8.60	2.02	1.01	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.06	10.83	11.70	7.37	2.17	1.73	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.97	14.38	14.82	10.02	1.31	0.87	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	23.75	9.40	10.39	7.92	0.99	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	14.77	3.69	17.54	5.54	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	20.94	4.19	18.15	15.35	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	31.29	7.48	18.83	8.58	1.11	0.55	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	36.07	7.85	16.69	9.82	2.45	0.49	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	33.88	9.24	10.78	9.24	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	19.34	11.82	15.04	5.73	0.72	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	27.70	11.08	22.16	15.23	2.77	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	35.69	23.57	40.60	4.91	2.29	3.27	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	30.79	24.40	32.66	4.51	2.25	7.13	0.38	0.38
CD8+ T Cells, donor3	11383-118B6	54.03	32.32	33.08	7.83	1.51	6.06	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	10.09	2.75	4.36	3.90	0.46	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	6.47	2.40	3.35	4.55	0.96	0.48	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	9.03	2.19	4.38	3.01	1.09	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	8.11	6.00	5.40	3.60	0.60	0.30	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	9.60	1.92	2.88	3.84	0.48	0.48	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	6.37	5.23	3.41	3.87	0.45	0.68	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	8.26	4.13	4.35	3.04	0.65	1.30	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.47	3.68	2.63	3.95	0.53	0.00	0.26	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	6.57	4.46	2.35	4.46	0.94	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	6.64	5.43	3.92	6.04	2.11	0.60	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	5.81	4.94	3.78	4.65	0.58	0.29	0.00	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	6.39	5.60	2.93	6.13	1.07	0.00	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	6.57	10.07	3.06	6.57	2.19	2.63	0.00	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	10.02	10.93	6.83	5.01	1.37	0.00	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	8.95	7.46	3.73	3.73	0.00	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	8.28	2.52	6.12	3.96	0.36	0.00	0.72	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.78	2.59	3.45	2.59	0.58	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	8.72	5.66	4.24	4.24	0.24	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	8.87	5.39	3.17	4.44	0.32	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	8.92	6.77	5.54	2.46	0.92	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	5.77	6.09	3.21	6.09	0.64	0.64	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	8.03	4.97	4.21	5.74	1.15	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	8.28	3.94	3.55	5.52	0.39	1.18	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	5.29	2.27	1.51	0.76	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	20.88	14.45	16.86	4.82	2.41	0.00	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	18.88	16.09	11.89	6.29	1.40	1.40	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	20.04	20.04	15.03	5.01	1.00	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	62.14	0.00	14.62	5.48	1.83	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	8.89	5.93	3.95	4.94	0.49	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	12.42	14.73	6.10	4.95	0.84	0.74	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	10.40	3.81	4.51	6.93	0.00	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	12.79	6.04	6.75	3.55	0.36	0.36	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	13.77	7.62	4.66	7.17	0.57	1.02	0.23	0.00
Chondrocyte - re diff, donor2	11339-117F7	16.11	17.91	7.16	16.11	3.58	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	25.07	6.87	10.11	8.49	0.00	0.81	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	25.71	9.87	8.61	4.82	0.92	0.57	0.34	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	19.24	7.05	6.41	4.70	0.64	0.86	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	18.05	10.62	7.52	5.75	1.59	0.80	0.09	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	36.04	5.87	12.56	4.49	1.74	1.19	0.09	0.09
Corneal Epithelial Cells, donor1	11526-119I5	3.95	2.20	2.42	1.98	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	2.28	2.28	3.41	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.11	3.58	3.83	3.32	0.26	0.26	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	13.70	19.32	3.14	11.06	2.31	0.83	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.99	16.40	5.05	14.51	1.58	1.26	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	20.70	0.00	17.25	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.59	22.03	2.81	11.88	1.94	1.19	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	28.01	11.27	14.35	1.71	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	15.02	41.13	9.14	11.75	1.31	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.78	22.75	6.78	7.74	0.97	1.45	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	5.00	10.34	5.17	5.50	0.50	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	5.87	5.28	2.93	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	5.66	5.94	4.52	5.37	1.13	0.28	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	5.11	8.26	1.97	2.36	2.36	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	12.80	3.49	3.78	0.87	0.29	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	7.06	16.94	3.29	5.65	1.88	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	6.14	10.52	1.93	2.28	0.88	0.53	0.18	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.86	15.52	4.43	4.88	0.66	0.66	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	13.08	22.82	5.78	7.00	1.52	0.30	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	20.30	30.73	5.64	7.05	2.54	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	8.02	2.97	4.16	3.27	0.89	0.30	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	6.77	5.21	4.17	2.08	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	6.95	8.65	2.13	4.11	0.57	0.14	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	11.20	18.01	5.20	7.20	0.40	0.40	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	6.81	3.67	3.67	2.10	0.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	11.43	21.87	7.08	9.57	1.49	0.12	0.87	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	20.86	11.95	6.52	6.74	1.09	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	16.37	14.53	6.72	7.21	1.10	0.12	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	11.38	4.55	4.55	1.14	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	6.29	2.10	3.49	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.93	9.26	4.55	5.65	0.47	0.16	0.00	0.16
Eosinophils, donor1	12244-129H3	45.74	91.48	45.74	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	44.56	419.17	64.36	95.72	42.91	3.30	1.65	3.30
Eosinophils, donor3	12246-129H5	78.47	231.84	49.94	53.50	17.83	17.83	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	2.93	1.71	1.95	0.98	0.00	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	17.65	4.93	10.26	8.21	0.82	2.05	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	5.47	2.85	1.86	1.75	0.44	0.22	0.22	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	10.08	5.31	3.03	6.07	0.54	0.11	0.33	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	12.25	10.07	6.31	7.03	1.33	0.49	0.36	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	18.83	8.05	8.05	4.78	0.41	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	13.50	7.80	7.59	6.54	0.95	0.21	0.32	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.03	5.80	7.11	4.22	0.26	0.00	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.27	12.29	6.31	7.31	0.66	0.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	9.53	10.43	2.72	5.44	0.91	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	7.58	4.55	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.67	7.73	6.15	4.89	1.42	1.26	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	21.22	16.67	5.76	10.91	1.52	1.52	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	17.26	10.66	6.35	5.84	0.89	0.89	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	12.73	12.13	5.31	6.52	0.76	0.15	0.30	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	14.07	4.02	3.89	4.29	0.94	0.27	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	19.41	15.10	6.90	6.47	0.86	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	24.90	7.32	17.58	5.86	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	11.53	7.15	3.23	3.23	0.23	0.23	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	15.43	7.97	8.82	8.14	1.70	0.51	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	7.28	10.10	3.76	4.46	0.23	0.47	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	4.72	5.19	1.42	2.36	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	7.37	15.23	3.99	8.82	1.09	0.60	0.12	0.00
Fibroblast - Dermal, donor4	11450-119A1	15.26	10.29	6.67	7.69	0.79	1.36	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	11.34	11.51	5.76	8.72	1.92	0.35	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	17.38	13.16	8.12	8.93	1.62	0.49	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	16.24	12.91	6.04	8.54	1.67	1.04	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	11.00	11.27	7.34	9.17	1.57	0.79	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	12.91	12.12	5.53	10.28	1.19	1.32	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	19.24	13.34	7.44	11.80	0.97	0.58	0.00	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	21.82	11.43	10.39	6.23	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	15.33	8.46	5.81	5.29	0.53	0.35	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	8.73	14.97	4.99	10.29	1.09	0.31	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	8.25	13.12	4.33	13.25	0.95	0.27	0.27	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	7.76	4.94	2.82	7.41	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.68	11.26	4.09	9.21	1.32	0.15	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.73	7.91	7.50	9.14	1.23	0.95	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.76	12.61	8.56	11.19	1.21	0.66	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	22.60	6.75	9.39	6.02	1.03	0.44	0.88	0.00
Fibroblast - Lung, donor1	11270-116H1	2.72	4.08	1.36	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	13.43	5.97	4.48	13.43	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	9.29	9.50	3.38	5.06	0.84	1.48	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	14.99	4.17	2.50	4.17	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	1.40	6.99	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.64	0.84	1.12	0.56	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	13.40	8.12	2.44	6.09	0.81	0.00	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	5.96	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.16	8.73	7.56	8.34	0.78	0.58	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	26.24	13.65	10.01	9.71	1.37	0.76	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	14.08	31.52	7.04	16.83	1.22	0.61	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	13.36	14.50	5.34	12.21	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.72	10.53	7.56	8.91	1.35	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.25	6.84	6.03	4.87	1.16	0.23	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	8.84	13.60	5.08	7.85	1.66	0.55	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.13	8.74	3.25	3.66	1.22	0.00	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	2.00	2.67	2.67	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	9.09	8.70	3.95	7.12	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	19.45	11.11	7.74	5.95	0.79	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	16.70	7.99	7.82	5.15	0.53	0.36	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	18.72	8.67	4.73	7.88	0.20	0.20	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	8.42	6.92	2.41	3.91	0.60	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	18.35	9.28	5.61	8.64	1.08	0.86	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	23.28	10.63	7.34	3.80	0.76	0.76	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	12.80	11.32	4.92	8.20	0.98	0.16	0.16	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	9.82	8.82	3.61	6.42	1.20	0.80	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	14.97	13.46	5.12	12.06	1.41	0.90	0.30	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	21.16	8.76	6.04	7.25	3.02	0.60	0.00	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	17.81	6.05	4.39	6.71	1.16	0.99	0.25	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.34	8.72	6.84	9.92	1.54	0.00	0.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	14.45	9.20	7.88	6.24	0.66	1.31	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.39	8.95	8.52	10.44	1.17	0.21	0.21	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	9.95	8.60	4.55	6.92	1.01	0.00	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	12.39	9.57	6.12	5.49	1.10	0.47	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	177.28	22.16	22.16	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	23.53	16.56	6.97	13.94	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	9.71	8.67	6.93	6.07	0.52	0.52	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	7.81	16.40	4.94	11.71	1.30	0.26	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.67	14.82	6.13	12.26	1.28	0.51	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	22.20	6.12	6.89	3.83	2.30	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	22.33	4.47	11.49	1.91	1.91	1.28	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	77.88	8.56	22.54	6.56	1.71	0.57	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	50.19	3.86	17.92	1.93	0.55	0.28	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	33.34	3.65	8.68	2.51	0.46	0.46	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.40	7.73	11.49	2.58	0.20	0.79	0.99	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	36.48	2.11	10.04	2.38	0.26	0.53	1.59	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	28.05	4.89	9.46	3.91	0.00	0.65	0.65	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	80.04	8.84	22.11	5.31	2.65	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	53.99	13.71	30.38	6.22	1.84	0.99	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.58	11.21	26.85	7.27	0.86	0.62	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	46.20	14.51	22.83	2.95	2.15	0.81	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.29	5.45	20.57	3.35	1.12	0.62	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.14	6.64	16.75	2.91	1.11	0.42	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	27.85	9.35	13.21	4.88	0.61	0.61	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.17	8.90	11.41	3.88	1.37	0.68	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.25	8.10	15.70	2.99	1.12	0.62	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	36.94	11.37	19.89	3.50	0.66	0.66	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.34	8.86	11.82	2.95	1.18	0.59	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	34.18	8.42	15.90	4.13	0.95	1.11	0.16	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	25.25	16.31	15.42	3.80	1.79	0.45	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.36	11.49	9.07	4.64	0.81	0.60	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	32.23	11.71	14.42	3.90	1.36	0.17	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	29.00	12.33	14.01	4.08	1.68	0.80	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	14.26	10.61	4.68	5.10	1.25	0.62	0.94	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.03	11.44	4.44	5.98	1.71	0.34	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.44	8.52	14.72	4.32	0.89	0.44	0.33	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.04	10.40	15.22	5.41	1.25	0.83	0.25	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	23.68	12.05	10.41	4.90	1.02	0.20	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	17.74	11.97	10.11	3.30	1.24	0.21	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	27.79	8.07	12.45	4.38	1.15	0.12	0.23	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	20.35	15.51	9.01	4.17	0.33	0.33	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	13.23	11.46	7.27	3.97	0.88	0.44	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	35.42	11.93	16.73	5.04	0.74	0.37	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	18.80	14.26	10.37	3.73	1.95	0.49	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	21.49	12.83	13.15	4.49	0.32	0.32	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	19.90	8.15	11.75	5.12	1.04	0.57	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.50	12.81	7.28	5.54	1.58	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.33	12.16	10.03	5.17	1.22	0.61	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.74	10.14	10.77	5.33	1.36	0.63	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	17.13	11.86	8.12	3.29	1.10	0.22	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.72	12.06	10.38	5.05	1.12	1.12	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	10.93	15.46	4.44	7.87	1.76	0.19	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.70	14.17	4.55	6.95	1.60	0.80	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	11.48	21.88	8.42	6.89	2.45	0.15	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	15.03	15.29	6.48	6.22	1.42	1.17	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.55	14.37	5.42	5.96	1.36	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	14.38	16.41	9.40	7.37	1.29	0.18	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	14.91	13.16	8.99	4.39	0.88	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	21.82	9.92	6.94	6.94	0.99	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	13.06	15.70	8.05	8.57	2.37	0.26	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.91	15.54	7.87	5.65	2.22	1.21	0.81	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	24.91	12.71	10.67	8.64	3.56	1.52	0.76	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	86.19	17.12	41.21	6.37	3.78	0.40	0.60	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	66.41	15.41	32.05	6.16	2.16	0.77	0.15	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	78.15	12.68	32.12	4.09	1.64	0.41	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	15.96	5.32	7.82	1.56	1.56	0.31	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	16.67	4.24	10.17	2.26	2.26	0.57	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	46.58	4.61	12.91	3.69	0.46	0.92	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	34.65	7.42	14.85	9.90	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	24.76	9.67	17.02	3.48	0.77	0.77	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	11.23	4.81	25.67	1.60	1.60	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	15.65	6.96	8.69	3.48	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.09	6.18	13.34	2.93	1.30	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	30.06	7.41	18.53	2.88	1.24	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	36.65	10.00	23.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.05	5.31	12.86	3.36	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	26.15	7.52	13.73	3.60	0.33	0.98	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	18.45	5.87	6.71	1.68	0.84	0.00	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	28.31	7.00	11.77	2.23	0.95	0.32	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	21.74	5.77	8.83	3.06	1.02	1.02	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	4.18	4.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	32.64	6.30	8.59	1.15	0.57	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	18.94	2.96	5.92	2.07	0.00	0.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	11.86	5.08	8.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	24.44	10.36	15.33	5.38	1.24	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	19.79	6.21	11.51	3.45	1.38	0.23	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	5.27	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.22	4.23	9.61	2.69	1.15	0.38	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	19.88	7.17	11.08	2.61	0.33	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	12.71	5.35	6.69	2.01	0.67	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.37	4.24	13.48	3.08	0.39	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	29.78	13.69	16.43	6.85	2.05	2.05	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	4.97	12.42	7.45	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	32.09	4.72	7.55	1.42	0.47	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	33.80	9.66	12.67	3.02	1.21	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	5.09	8.14	2.54	1.02	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	30.31	4.79	9.17	3.19	1.20	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	44.40	4.93	13.81	3.95	0.49	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	3.54	9.44	5.90	2.36	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	23.34	2.92	12.25	0.00	0.58	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	42.13	7.46	17.12	2.19	0.44	0.00	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	36.45	3.39	12.72	2.54	0.00	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	13.73	3.58	11.34	5.37	0.60	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.50	5.34	7.28	5.34	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	2.28	2.28	5.71	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	11.23	7.48	4.99	4.57	0.83	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1.12	3.37	1.12	1.12	1.12	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	14.91	12.05	4.76	6.34	0.63	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.03	4.60	2.51	6.27	0.42	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	11.49	6.96	3.13	5.34	1.28	0.70	0.00	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.18	6.58	4.90	4.73	0.68	0.68	0.34	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.20	5.46	4.32	3.64	1.37	0.46	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	11.59	5.47	2.84	3.83	0.98	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	13.75	5.37	3.44	5.80	0.64	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	12.70	5.60	3.66	4.52	1.29	0.65	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	10.34	7.97	3.74	4.48	1.62	0.25	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	13.72	7.21	4.63	3.09	0.51	0.17	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	15.70	6.41	2.56	6.73	0.64	0.96	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	7.28	5.04	2.80	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	1.73	0.87	2.16	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	7.93	10.58	2.64	10.58	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.59	3.88	2.12	1.76	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	2.91	1.45	2.18	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	8.22	11.36	3.50	5.59	1.22	0.17	0.00	0.00
Hepatocyte, donor1	11523-119I2	47.21	12.11	10.90	3.63	3.63	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	37.71	23.70	23.70	5.39	1.08	0.00	1.08	2.15
Hepatocyte, donor3	11684-122I1	36.81	7.98	15.34	5.52	2.45	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	9.79	10.44	5.22	7.83	0.65	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	19.75	7.69	12.06	5.24	1.22	0.87	0.35	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.72	12.76	3.02	5.21	0.96	0.82	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	6.37	12.74	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	13.35	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	16.61	12.46	2.77	4.15	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	7.51	5.01	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	11.87	0.00	0.00	23.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	10.25	2.56	10.25	5.13	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	3.25	4.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	10.00	5.00	3.33	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	10.89	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	15.88	3.97	6.62	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	12.20	8.87	1.11	1.11	1.11	1.11	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	20.95	0.00	5.24	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	6.93	6.30	0.00	1.26	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	7.73	3.09	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	17.44	6.46	4.52	1.29	0.00	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	9.66	8.05	9.66	1.61	1.61	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	16.30	6.52	2.44	5.70	0.00	1.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	3.36	4.20	1.68	0.84	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.07	7.23	6.43	4.82	0.80	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	5.54	4.62	1.85	1.85	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	15.08	0.00	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	4.25	4.72	2.83	0.47	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	7.26	2.72	4.53	4.53	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	11.84	6.46	4.30	6.46	0.00	2.15	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	10.16	11.43	6.35	1.27	0.00	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	11.48	4.46	2.55	0.64	0.64	1.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	3.65	5.47	5.47	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	31.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.85	4.28	2.14	0.00	0.00	0.71	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	16.59	9.95	0.00	6.64	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	8.33	3.09	3.40	1.85	0.62	0.62	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	17.56	1.76	5.27	7.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	9.43	9.43	3.14	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	4.87	3.48	5.56	0.70	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	15.49	17.70	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	6.48	12.97	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	5.23	5.23	3.49	1.74	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	13.50	9.00	13.50	0.00	0.00	4.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	22.40	2.13	7.47	1.07	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	19.40	5.54	1.39	4.16	1.39	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	11.40	8.55	5.70	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	15.65	2.76	3.68	3.68	0.92	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	6.05	6.05	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	7.40	2.11	9.52	1.06	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	7.34	7.02	4.73	4.49	1.31	0.82	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	5.86	2.34	1.17	1.17	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.56	12.49	3.79	7.10	1.42	0.66	0.09	0.00
Keratinocyte - oral, donor1	11251-116E9	24.18	13.40	14.08	9.65	1.48	0.23	0.00	0.00
Keratocytes, donor1	11527-119I6	15.47	5.85	3.78	3.09	0.34	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	3.52	0.00	2.34	4.69	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	25.09	7.11	8.89	4.74	0.20	0.59	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	248.36	19.78	59.34	8.79	0.00	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	7.55	6.47	8.63	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	28.37	9.69	10.38	3.23	0.81	0.46	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	28.36	16.85	15.94	7.87	2.02	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.89	6.76	4.15	2.49	0.83	0.24	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	4.19	3.91	1.95	3.91	1.67	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	14.01	10.07	6.30	4.72	0.79	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.06	6.45	1.08	2.15	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	3.15	1.58	1.58	2.84	0.63	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.36	2.26	2.26	0.75	0.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	15.59	10.67	3.28	2.87	0.41	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.56	3.54	1.01	1.52	0.76	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.01	3.24	4.22	2.39	0.84	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.12	6.72	1.98	3.56	1.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	7.76	4.65	3.30	2.52	0.58	0.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	4.07	1.30	1.85	1.30	0.19	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.19	3.83	5.23	4.18	0.35	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.72	4.77	1.91	1.19	0.95	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.87	3.30	2.20	1.79	0.14	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	9.24	5.24	2.77	5.54	0.00	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.05	1.56	0.31	1.87	0.00	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.05	2.74	3.11	1.46	0.91	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	9.54	5.59	3.29	3.29	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.98	1.17	2.34	2.05	0.29	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	6.72	1.99	2.49	0.75	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	9.70	4.36	5.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	9.16	8.62	3.23	3.77	0.27	0.27	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	8.78	3.78	4.39	1.51	0.45	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	2.59	2.59	2.59	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	9.63	9.21	2.72	4.19	0.42	0.42	0.42	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.22	3.91	3.46	1.50	0.15	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	9.63	4.13	4.82	0.69	0.69	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	6.40	5.83	1.69	1.88	0.38	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.00	2.33	2.23	1.17	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	9.21	7.27	3.88	2.42	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	6.62	2.98	2.32	2.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.96	3.10	2.60	1.98	0.25	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	8.14	8.51	1.48	5.18	2.59	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	5.68	5.68	2.22	2.96	0.99	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.67	2.20	1.65	1.10	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	10.29	8.36	5.47	4.18	0.96	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	10.35	4.87	2.74	3.35	0.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.50	6.30	5.60	4.06	0.56	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	9.60	9.24	3.91	3.20	1.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.88	0.97	1.94	1.94	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.29	2.18	1.56	0.93	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	12.53	6.80	4.30	2.86	0.36	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	3.92	2.61	1.31	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	1.65	1.41	0.47	0.47	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	13.12	7.92	2.85	2.48	0.74	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	4.61	2.05	2.05	0.77	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	5.97	3.58	2.98	1.79	0.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	15.86	6.80	11.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	13.04	6.90	4.60	4.60	2.30	1.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	16.33	5.94	2.97	7.42	1.48	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.66	5.92	3.81	3.39	0.42	1.69	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	11.96	9.85	4.22	3.52	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	17.75	3.74	5.60	2.80	0.93	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	5.15	6.18	5.15	1.55	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	8.33	1.19	3.57	1.19	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.40	7.24	3.85	5.20	1.13	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	16.00	6.11	3.49	6.11	2.04	2.33	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	20.71	11.25	5.85	3.60	1.35	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.23	7.18	4.34	4.20	1.08	0.54	0.41	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.43	2.57	3.59	5.14	2.05	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	17.29	6.35	6.35	9.17	1.41	1.06	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	8.00	4.00	4.66	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	13.75	7.64	4.58	8.15	2.55	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	18.41	13.07	7.20	6.14	0.53	1.33	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	21.54	11.53	8.88	6.42	1.13	1.51	0.38	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	17.18	4.91	5.52	3.68	1.23	0.61	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.05	11.42	4.89	6.52	1.63	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.45	8.95	6.66	5.62	1.25	2.08	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	17.66	7.29	5.89	5.89	2.24	1.68	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	11.33	6.18	5.15	0.00	0.00	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	20.90	9.00	5.23	8.13	2.61	0.58	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.95	6.28	5.68	5.98	1.20	1.49	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	20.47	9.96	3.87	7.19	0.55	1.66	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	22.62	6.36	5.30	5.66	0.35	1.06	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	17.70	3.69	5.53	4.06	2.21	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	4.61	2.30	6.91	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.05	9.21	6.14	4.99	1.15	0.77	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.72	4.53	5.10	3.40	1.70	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	13.13	9.85	5.74	4.10	1.64	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	12.65	8.13	7.68	5.42	2.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	12.93	5.75	5.75	5.03	4.31	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	11.20	4.48	4.48	0.00	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	21.92	10.40	5.20	6.69	0.37	1.11	1.11	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	12.92	6.46	3.45	4.74	2.15	0.43	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	15.41	6.85	3.43	4.28	1.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	17.99	10.33	5.00	3.33	2.00	0.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	12.67	3.02	3.02	7.84	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	11.38	6.40	7.82	3.55	0.00	1.42	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	17.53	8.25	3.78	5.50	2.06	0.00	0.69	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	15.03	6.98	2.15	3.76	2.68	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	9.43	8.08	2.69	0.00	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	20.00	7.78	4.07	5.56	1.11	0.37	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	18.61	5.81	5.81	5.81	2.33	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	5.29	2.12	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.61	8.40	7.20	4.00	1.20	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	14.54	3.63	5.09	3.63	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	22.23	9.96	3.83	4.60	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	10.36	3.95	4.44	0.99	0.49	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	17.88	5.65	6.59	0.94	1.88	0.00	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.11	11.06	7.54	6.03	1.51	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.48	4.51	4.51	7.21	0.90	0.90	0.45	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	6.88	8.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.15	11.58	5.34	6.68	1.34	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.42	7.43	6.65	3.91	1.56	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	19.13	8.58	1.32	7.92	0.00	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	14.01	11.94	5.71	7.78	0.52	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	27.13	10.06	8.75	5.69	1.31	2.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	17.89	5.59	3.91	4.47	0.56	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	15.46	8.83	8.83	5.30	1.32	1.32	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	17.36	10.80	7.71	4.63	1.93	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.27	8.10	7.09	5.57	2.03	0.51	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	13.94	11.05	3.84	3.84	0.00	0.48	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.53	11.13	5.96	6.76	1.99	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.01	7.29	2.43	4.86	0.61	1.22	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.07	7.61	3.46	4.84	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	18.24	9.12	6.46	5.70	1.90	0.38	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	14.46	7.75	5.16	5.16	0.52	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	4.84	5.44	6.65	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	19.96	6.02	5.07	5.70	2.54	0.95	0.63	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	22.39	6.93	4.26	3.20	0.53	2.13	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	9.19	4.60	3.45	1.15	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.51	8.74	6.69	4.11	0.51	0.51	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	19.81	6.37	2.83	0.71	1.41	2.12	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	19.86	3.40	4.54	5.67	1.13	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.31	8.32	6.24	3.74	1.25	0.83	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	15.66	3.92	7.83	3.92	2.35	1.57	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.78	4.59	5.01	3.34	0.42	1.25	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	13.01	2.32	5.11	2.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	5.35	3.35	6.02	2.01	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	18.18	5.88	4.81	3.74	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	20.61	10.10	4.85	6.47	0.81	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	3.67	1.84	4.59	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	10.67	0.89	1.78	4.45	0.89	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	14.82	9.12	3.42	4.56	0.57	1.14	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	13.04	3.83	3.07	5.37	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	11.49	3.83	3.83	4.38	1.09	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	15.59	3.56	4.01	3.56	1.34	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.44	4.42	4.42	6.50	1.30	0.78	0.78	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	4.64	3.98	5.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	2.08	10.39	4.16	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	16.18	13.90	4.79	11.40	2.96	0.23	0.23	0.23
Macrophage - monocyte derived, donor2	11313-117C8	8.07	14.31	2.39	12.48	1.47	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	13.63	18.22	4.85	10.88	1.84	0.66	0.52	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	3.19	16.99	3.72	7.43	2.66	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	18.86	16.80	10.77	13.47	3.01	0.79	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	13.06	15.01	7.37	7.78	2.64	0.97	0.14	0.14
Mammary Epithelial Cell, donor1	11273-116H4	14.75	26.60	11.26	16.94	3.19	1.00	0.30	0.00
Mammary Epithelial Cell, donor2	11350-117G9	12.74	17.66	6.66	15.06	0.87	0.29	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	4.74	3.74	2.99	2.49	0.50	0.25	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	13.56	77.28	9.49	32.54	11.52	2.03	2.03	6.10
Mast cell, donor1	11563-120D6	19.68	18.49	9.41	13.52	1.41	1.95	2.05	0.11
Mast cell, donor2	11565-120D8	46.06	14.56	16.34	11.89	2.38	0.89	3.27	0.00
Mast cell, donor3	11566-120D9	59.66	18.24	17.11	13.73	1.58	2.03	4.95	0.00
Mast cell, donor4	11567-120E1	40.60	15.60	13.83	10.46	1.95	1.06	4.43	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	27.28	6.99	12.42	13.31	2.99	0.22	0.78	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	5.84	15.18	5.84	16.93	2.92	0.00	5.84	0.58
Mast cell, expanded, donor5	11939-126A4	20.08	3.56	8.72	9.18	1.61	0.23	2.06	0.11
Mast cell, expanded, donor8	11941-126A6	12.22	12.72	7.20	11.38	1.34	1.00	2.85	0.33
Melanocyte - dark, donor1	11502-119F8	16.91	18.31	6.17	4.88	3.28	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	6.58	7.27	6.92	4.85	0.35	0.69	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	8.91	18.83	5.65	6.81	2.25	0.65	0.00	0.07
Melanocyte - light, donor1	11274-116H5	3.29	7.99	3.29	2.35	0.47	0.24	0.24	0.24
Melanocyte - light, donor2	11351-117H1	6.82	1.36	3.41	2.73	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	5.20	6.07	4.34	0.00	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	11.04	12.81	6.46	5.62	0.83	0.21	0.10	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	7.26	12.91	2.69	4.57	1.34	0.27	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	11.25	19.55	5.36	4.82	0.54	1.34	0.00	0.00
Meningeal Cells, donor1	11493-119E8	11.91	5.58	5.09	5.21	1.36	0.12	0.12	0.00
Meningeal Cells, donor2	11573-120E7	15.85	2.64	6.16	7.04	0.44	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	13.53	12.06	6.60	7.74	1.47	0.49	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	22.81	7.41	8.27	8.84	0.00	0.57	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.76	6.94	4.43	4.53	0.81	0.60	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	0.00	0.00	2.62	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.89	11.48	2.15	6.46	0.00	2.15	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	12.07	10.59	5.72	5.72	0.85	0.85	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.53	10.05	3.02	7.54	0.00	1.51	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.37	3.52	1.54	2.42	1.32	0.66	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	2.19	0.73	2.19	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.91	5.12	1.84	2.05	0.61	0.20	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.30	10.67	4.85	8.73	1.25	0.42	0.42	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.81	2.60	2.97	1.49	0.37	0.37	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	19.34	10.53	9.21	4.87	1.32	0.79	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	3.26	4.15	2.97	0.89	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	7.04	5.12	1.92	3.84	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	12.41	13.11	6.03	9.22	1.77	1.77	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.20	9.69	9.07	6.25	0.31	0.63	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	7.98	5.08	2.18	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	21.21	3.98	9.55	5.04	0.53	0.00	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	9.51	5.51	4.00	3.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	13.87	9.83	7.23	5.35	0.87	0.65	0.36	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	54.01	4.05	5.40	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	11.08	14.53	4.19	9.60	1.72	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.83	13.55	4.42	10.60	0.88	0.00	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	0.00	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	9.61	12.40	2.48	9.30	0.62	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.64	11.20	2.90	10.99	1.04	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	27.79	2.32	6.95	6.95	2.32	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.01	16.27	1.00	10.76	1.75	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.17	11.64	4.65	9.78	4.19	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.55	12.40	3.66	6.91	1.63	1.83	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.52	12.67	2.77	7.13	2.77	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	9.73	7.96	1.77	2.65	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	5.70	11.40	3.04	14.44	1.90	1.14	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	19.74	0.00	2.63	3.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	5.94	22.71	1.49	8.70	2.12	0.64	0.21	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	4.60	7.37	8.29	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.54	19.97	2.98	7.75	1.49	0.89	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	1.68	11.74	5.03	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.52	20.07	0.75	9.03	2.76	1.25	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	7.61	14.50	2.61	7.37	1.66	0.24	0.24	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.37	6.08	2.21	4.42	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.68	33.39	1.38	5.30	1.84	0.46	0.00	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.26	18.30	2.31	11.36	1.47	0.21	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.71	26.29	2.85	8.15	1.22	0.20	0.20	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.72	24.89	1.72	8.15	2.57	0.21	0.43	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.34	17.78	2.89	11.11	1.33	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	20.64	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.48	27.16	1.97	6.35	2.85	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.14	13.18	2.53	8.11	0.51	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	8.28	8.28	6.63	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	13.05	33.97	4.08	6.52	2.45	1.09	0.27	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.76	15.88	1.47	10.29	1.76	0.29	0.00	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	10.90	2.18	4.36	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	25.47	2.88	9.61	1.44	1.44	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	5.20	19.61	3.20	12.81	1.20	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	5.48	12.34	1.37	1.37	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.01	36.54	3.00	8.01	2.50	0.00	1.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	53.89	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	42.81	6.12	12.23	6.12	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.26	29.78	3.94	10.51	3.94	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	14.35	6.62	1.10	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	16.01	11.53	2.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.68	35.45	4.21	8.93	2.73	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	16.01	0.70	9.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	17.68	15.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.55	31.11	4.79	9.91	2.05	0.34	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.56	14.44	3.50	6.56	1.31	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	34.80	4.97	11.72	3.20	1.42	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	8.42	26.37	3.09	10.94	2.81	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	7.07	22.86	3.74	12.05	2.49	0.42	0.00	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	19.23	8.16	8.74	4.08	1.17	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.84	23.83	5.73	12.37	1.51	2.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.43	22.96	3.34	10.02	2.09	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	0.00	36.09	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	22.17	1.85	6.46	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	18.21	3.98	16.50	0.57	0.00	0.57	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.44	12.57	5.67	9.40	1.11	1.38	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.52	20.47	3.63	11.66	1.55	1.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	15.87	20.16	5.15	12.44	1.29	0.86	0.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	4.45	10.16	3.18	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	8.54	12.28	2.94	6.14	1.60	1.07	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	15.86	21.25	10.48	11.67	2.39	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	14.97	12.43	7.63	6.36	0.71	0.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.64	21.66	3.82	5.73	1.27	2.23	0.00	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	17.03	20.57	7.52	11.72	1.55	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.68	9.10	7.58	6.45	1.52	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	13.07	20.17	4.83	7.39	2.27	0.85	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.29	24.33	7.13	14.99	2.21	0.00	0.49	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	23.46	8.47	12.38	2.61	0.00	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	19.11	5.59	8.82	1.76	1.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.70	21.05	8.94	11.53	1.15	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	20.20	20.20	9.89	14.84	2.47	0.82	1.24	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.23	14.29	2.38	8.04	1.49	0.60	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	22.60	3.77	15.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	24.95	3.56	8.91	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	8.21	21.36	2.96	8.54	3.61	0.33	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	2.10	16.83	2.10	6.31	1.05	1.05	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	4.15	12.65	1.19	10.28	1.19	0.40	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1.86	10.24	0.93	9.31	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	5.26	22.91	2.25	9.01	3.00	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.53	13.05	2.13	5.59	0.80	0.53	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	8.37	19.57	2.83	10.41	1.81	0.57	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	7.37	2.21	3.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	7.33	22.72	3.30	9.53	1.83	0.00	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	12.44	3.11	12.44	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.69	33.67	3.21	14.96	3.74	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	11.59	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	13.13	6.06	4.04	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	21.93	1.69	11.81	2.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	38.13	1.36	16.34	10.90	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.36	26.70	1.27	3.18	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	38.87	4.86	9.72	6.48	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	34.74	1.51	3.02	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	199.86	0.00	17.13	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	137.02	9.79	6.52	13.05	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	66.53	0.00	4.75	4.75	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	112.94	12.55	0.00	25.10	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	13.14	13.14	4.74	7.54	1.72	0.86	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.04	12.54	4.18	7.32	1.57	2.61	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	2.67	0.67	6.01	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.01	6.26	1.67	3.34	0.83	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	19.20	9.51	8.37	5.32	1.14	0.95	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	51.07	7.98	20.75	6.38	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.68	2.72	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	12.86	7.35	12.86	3.68	3.68	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	2.93	2.51	0.42	3.35	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	6.51	4.88	2.79	3.72	0.23	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	4.32	3.24	1.08	1.62	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.56	5.68	3.99	6.10	0.84	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	11.13	22.27	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	3.97	2.48	2.48	6.95	0.99	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	9.47	3.25	4.06	4.60	0.81	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.95	2.49	0.45	2.95	0.45	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	3.76	4.25	1.14	2.94	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.11	6.01	4.01	4.01	0.36	1.09	0.00	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	2.65	3.18	2.12	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.20	1.80	0.00	2.40	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	27.57	3.61	10.17	3.61	0.33	1.31	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.42	1.46	0.65	1.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.70	4.94	4.76	4.76	0.00	0.88	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	1.41	2.81	2.11	2.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	3.22	0.92	5.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	4.50	3.53	1.29	2.89	0.64	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	31.38	6.90	10.69	1.72	0.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	108.72	22.76	22.76	12.64	0.00	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.04	4.01	5.57	2.90	0.22	0.45	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	3.81	1.69	1.69	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.78	2.61	3.56	1.90	0.00	0.95	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	2.58	5.15	0.43	3.43	0.00	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	27.08	9.03	36.11	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.33	3.33	1.00	4.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.68	3.16	9.92	2.71	0.00	1.80	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	3.97	3.17	1.98	2.78	1.59	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	1.86	2.79	0.93	3.71	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	12.49	5.68	6.43	3.78	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.24	2.93	0.98	0.98	0.98	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.54	1.74	2.61	2.18	0.44	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	6.33	6.78	5.43	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	5.29	3.53	0.00	2.65	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	3.99	4.65	1.99	0.66	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	2.98	3.97	0.99	2.48	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	3.45	3.45	1.91	1.15	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.94	3.93	3.63	2.72	0.60	0.30	0.60	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	16.80	6.19	7.07	2.65	0.44	0.88	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	1.36	3.39	1.36	1.36	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	61.31	15.33	30.66	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.05	1.83	2.44	3.05	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	11.33	1.89	4.09	2.83	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.15	1.21	0.61	1.21	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	5.54	2.37	2.37	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	41.94	7.94	18.14	3.40	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	20.23	25.29	40.46	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.94	12.17	3.98	5.22	3.23	0.75	0.25	0.00
Myoblast, donor2	11322-117D8	14.96	10.36	7.10	8.06	1.53	0.58	0.00	0.19
Myoblast, donor3	11398-118D3	16.31	11.27	4.04	7.57	1.35	0.17	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	16.78	6.71	12.55	2.92	0.44	0.29	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	36.90	18.76	47.97	6.77	2.15	2.77	0.92	0.62
Natural Killer Cells, donor2	11311-117C6	29.85	17.79	38.60	3.92	3.02	4.22	1.21	0.30
Natural Killer Cells, donor3	11387-118C1	25.95	29.63	31.66	5.15	2.02	5.71	0.74	0.37
Neural stem cells, donor1	11275-116H6	27.22	29.40	8.35	23.23	6.90	1.45	3.63	0.36
Neural stem cells, donor2	11352-117H2	82.80	19.26	7.70	13.48	5.78	1.93	0.00	0.00
Neurons, donor1	11494-119E9	38.69	21.62	15.93	3.41	1.14	2.28	0.00	1.14
Neurons, donor2	11574-120E8	46.23	8.15	15.63	4.40	0.88	0.66	0.22	0.00
Neurons, donor3	11655-122E8	23.84	8.22	6.58	4.93	0.82	0.82	0.00	0.82
Neutrophils, donor1	11233-116C9	78.88	93.73	63.10	38.98	5.57	7.42	3.71	0.00
Neutrophils, donor2	11314-117C9	60.88	72.47	34.79	34.79	8.70	5.80	0.00	0.00
Neutrophils, donor3	11390-118C4	148.43	155.15	82.46	72.69	7.33	4.28	3.05	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	24.46	8.43	10.57	7.48	0.83	0.47	0.47	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	10.09	5.86	6.19	3.58	0.00	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	17.25	3.41	5.01	5.41	0.80	0.40	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	10.05	7.43	3.99	6.47	1.93	1.51	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	10.86	13.32	3.62	6.80	0.87	0.72	0.00	0.14
Olfactory epithelial cells, donor3	11935-125I9	11.01	9.42	4.54	5.79	1.36	0.34	0.00	0.23
Olfactory epithelial cells, donor4	11936-126A1	18.51	11.20	7.79	6.72	0.78	0.68	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	25.28	19.26	15.65	10.23	1.20	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	11.27	2.98	3.83	2.34	1.06	0.43	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	3.43	2.29	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.07	1.24	1.86	2.48	0.62	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	3.32	2.15	1.37	0.98	0.78	0.20	0.00	0.00
Osteoblast, donor2	11354-117H4	24.58	14.75	9.83	9.13	0.00	2.11	0.00	0.00
Osteoblast, donor3	11426-118G4	13.15	8.00	5.87	7.46	0.71	0.53	0.00	0.18
Pancreatic stromal cells, donor1	11249-116E7	12.89	9.27	4.63	5.64	1.77	0.84	0.51	0.00
Pericytes, donor1	11491-119E6	7.01	1.78	1.34	1.00	0.33	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	12.90	1.81	2.94	1.58	0.45	0.23	0.23	0.00
Pericytes, donor3	11652-122E5	7.32	3.87	4.07	1.63	0.00	0.41	0.20	0.00
Perineurial Cells, donor1	11499-119F5	17.07	10.62	3.62	5.54	0.68	0.79	0.00	0.11
Perineurial Cells, donor2	11579-120F4	12.42	12.24	6.90	7.27	0.83	0.28	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.84	15.30	16.26	11.16	1.91	1.27	0.96	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	27.67	26.69	16.41	7.59	1.47	1.96	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	27.95	24.59	16.31	9.19	2.07	3.36	0.52	0.13
Placental Epithelial Cells, donor1	11278-116H9	15.31	5.26	5.50	2.15	0.48	0.24	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	13.31	2.22	1.11	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	7.85	2.75	2.55	2.75	0.79	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	6.33	5.70	2.53	5.70	1.90	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	6.38	5.63	2.25	6.00	2.06	0.38	0.75	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.44	9.14	5.74	4.57	1.04	0.13	0.00	0.13
Preadipocyte - breast, donor2	11328-117E5	14.41	9.01	6.30	8.56	0.90	0.45	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	12.89	7.57	5.54	7.25	1.07	0.64	0.43	0.00
Preadipocyte - omental, donor2	11329-117E6	13.09	13.09	3.49	8.29	1.31	0.44	0.87	0.00
Preadipocyte - omental, donor3	11403-118D8	17.48	14.32	8.88	7.16	1.86	2.01	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	4.92	4.92	5.91	2.95	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.69	3.69	3.07	3.69	0.92	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	12.22	18.06	6.02	13.10	1.77	1.24	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	5.11	14.30	2.38	11.07	1.02	1.19	0.17	0.00
Preadipocyte - visceral, donor1	11280-116I2	12.57	14.62	3.45	13.23	1.96	0.65	0.56	0.00
Preadipocyte - visceral, donor2	11357-117H7	10.58	12.89	2.76	11.04	1.84	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	8.36	9.82	3.13	10.14	0.84	0.31	0.31	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	17.05	6.94	9.20	3.62	1.51	0.91	0.75	0.15
Prostate Epithelial Cells, donor2	11331-117E8	12.05	14.35	8.67	7.04	1.90	0.81	0.54	0.00
Prostate Epithelial Cells, donor3	11404-118D9	36.31	5.39	12.61	4.78	0.92	0.18	0.31	0.06
Prostate Stromal Cells, donor1	11254-116F3	12.98	5.70	5.47	3.99	0.80	0.34	0.00	0.00
Prostate Stromal Cells, donor2	11332-117E9	14.52	7.89	6.45	5.56	0.90	0.18	0.00	0.00
Prostate Stromal Cells, donor3	11405-118E1	10.64	6.26	5.01	3.96	0.94	0.00	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.95	1.09	2.19	1.46	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.02	7.49	10.67	5.27	1.46	0.42	0.28	0.00
Renal Epithelial Cells, donor1	11517-119H5	4.57	1.52	2.03	1.52	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	2.85	2.85	3.56	0.00	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	20.64	9.00	13.23	5.93	0.95	0.64	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	4.09	3.40	0.68	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.93	5.53	3.64	3.23	0.94	0.40	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	14.21	10.21	9.77	9.32	2.66	0.67	0.44	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	0.67	2.00	2.66	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	7.26	1.76	3.74	0.66	0.22	0.22	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	3.13	1.88	1.88	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	4.16	1.39	2.50	0.55	0.55	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	13.15	4.56	5.91	4.83	0.81	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	8.43	3.37	2.53	2.11	1.27	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.56	4.44	3.66	2.12	0.39	0.19	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	24.11	4.15	9.33	3.63	0.52	0.26	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.52	3.41	2.84	1.71	0.28	0.28	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	4.12	1.03	1.03	0.00	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	17.81	3.76	11.04	1.51	1.76	0.00	0.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	40.49	10.82	19.38	8.15	0.94	1.47	0.27	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	7.15	1.79	3.57	0.00	0.00	0.00	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	16.51	3.30	5.50	1.65	0.00	1.10	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	20.88	1.16	14.50	0.00	1.16	0.58	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	21.45	2.47	7.93	2.08	0.00	0.39	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	12.02	2.58	5.06	2.09	0.50	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	11.71	3.01	6.13	1.90	0.45	0.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	18.61	4.84	9.30	3.60	0.37	0.74	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.59	2.21	5.36	1.86	0.47	0.35	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	13.87	2.54	6.01	2.77	0.23	0.46	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.03	3.15	6.85	2.19	0.41	1.37	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.16	2.27	4.08	1.97	0.45	0.76	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.62	1.61	5.91	1.43	0.54	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	14.63	4.16	8.61	2.01	0.29	0.57	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	12.66	2.36	5.04	1.72	0.43	1.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	13.94	2.88	5.97	2.43	0.00	0.89	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.74	2.68	5.74	2.29	0.57	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.32	2.33	5.50	1.12	0.09	0.93	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.29	3.38	6.76	2.07	0.56	0.75	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	21.50	3.98	7.70	2.12	0.53	1.73	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	15.96	3.60	5.74	2.24	0.19	0.39	0.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	13.75	2.86	7.64	3.06	0.38	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	16.87	3.84	5.87	2.88	0.43	0.64	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.61	2.24	5.61	1.12	0.00	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.18	2.91	6.84	1.88	0.34	1.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.50	1.46	7.29	1.28	0.55	0.73	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.53	1.72	5.27	1.59	0.49	0.49	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	14.51	3.49	6.45	1.88	0.13	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.15	2.59	6.84	1.65	0.47	0.47	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	11.11	1.98	7.74	1.39	0.40	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	12.86	3.27	5.61	1.40	0.47	1.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	14.72	4.56	4.15	2.70	0.21	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.05	2.21	5.53	1.55	0.66	0.44	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	11.07	2.09	5.43	2.51	0.42	0.63	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	13.46	4.04	4.71	3.10	0.40	0.54	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.01	3.07	6.30	1.53	0.51	0.85	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	11.95	3.08	6.17	2.12	0.19	1.35	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.76	4.47	4.99	2.58	0.17	0.69	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	13.85	1.51	4.25	2.19	0.82	0.82	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	11.33	3.45	6.24	2.13	0.49	1.97	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	16.70	3.24	8.01	2.39	0.17	0.68	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	10.95	2.37	5.92	1.92	0.44	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.86	5.60	8.26	2.13	0.00	0.27	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.87	2.63	8.30	1.66	0.28	1.66	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	10.71	1.43	6.19	1.19	0.95	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	18.14	2.62	9.47	1.21	0.60	0.40	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.24	3.39	6.03	1.88	0.19	0.47	0.09	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.96	2.45	6.29	1.40	0.00	1.05	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.00	3.32	8.76	2.12	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	9.67	4.04	5.87	1.96	0.24	0.37	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	27.22	5.53	18.63	3.64	0.58	1.75	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	9.73	4.87	4.26	0.00	0.61	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	9.04	3.62	5.73	2.41	0.00	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.44	2.26	5.65	1.13	1.13	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.28	4.19	9.59	1.50	0.30	0.90	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	16.65	2.01	8.15	1.42	0.47	0.71	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	8.96	0.64	4.70	1.49	0.43	0.85	1.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	18.03	4.81	6.01	1.20	0.00	1.20	0.60	0.00
Schwann Cells, donor1	11498-119F4	6.77	2.07	3.57	1.69	0.19	0.19	0.00	0.00
Schwann Cells, donor2	11578-120F3	3.40	6.80	20.41	6.80	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	10.73	10.08	4.60	6.13	0.66	0.00	0.00	0.22
Sebocyte, donor1	11220-116B5	12.05	10.96	7.67	6.57	2.74	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	7.81	8.27	5.06	7.81	0.46	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	12.37	5.15	2.89	1.86	0.62	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	1.66	13.25	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	8.47	11.30	2.82	2.82	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	23.75	2.46	8.18	3.87	0.26	0.53	0.18	0.00
Skeletal Muscle Cells, donor2	11358-117H8	5.06	0.72	2.17	0.00	0.00	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	4.18	3.34	3.34	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	9.74	7.38	1.73	6.13	0.47	0.79	0.00	0.00
Skeletal Muscle Cells, donor5	11455-119A6	10.55	6.69	2.23	7.13	0.15	0.74	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	19.24	8.62	6.93	7.23	0.77	0.31	0.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	18.52	9.32	5.67	7.94	0.88	0.25	0.00	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.40	5.42	7.71	5.56	0.29	0.14	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	13.99	11.51	5.65	7.14	0.99	0.79	0.10	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.93	3.54	5.98	3.96	0.76	0.59	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	12.30	2.90	2.90	1.45	2.17	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	5.23	2.61	1.93	2.89	0.28	0.14	0.00	0.00
Skin - palm, donor1	10286-104F7	83.27	0.00	34.92	8.06	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.63	5.19	3.75	3.32	0.43	0.43	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	9.00	9.81	9.81	0.00	3.27	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	4.28	5.58	1.69	4.15	0.91	0.26	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	25.86	10.70	15.85	7.37	1.25	0.70	0.56	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	23.63	10.41	16.32	7.17	0.84	1.41	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	24.53	15.22	9.52	11.00	1.48	1.27	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	39.57	12.07	18.29	6.75	0.60	1.57	0.45	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.50	15.74	9.57	8.02	0.93	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.23	6.67	7.56	4.22	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.93	4.11	7.05	7.05	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.85	4.86	5.08	2.65	0.22	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	3.15	2.76	1.97	2.76	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.18	7.73	3.86	6.18	0.77	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	11.01	5.00	8.01	5.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.45	5.32	3.73	2.66	0.93	0.93	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.30	13.74	6.65	9.31	1.11	0.66	0.44	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.32	8.45	7.17	9.86	2.69	0.90	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.35	7.81	6.51	6.19	1.63	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.29	15.06	6.50	7.68	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	12.96	10.96	3.70	4.27	0.85	0.43	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.21	0.98	2.28	1.95	0.81	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.49	4.57	9.74	4.26	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	8.08	3.28	2.53	4.55	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	12.24	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.81	3.34	4.77	3.34	0.00	0.95	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.84	4.87	8.70	3.54	0.88	0.29	0.15	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.78	9.90	6.46	2.80	1.29	0.86	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	12.18	9.45	6.51	6.72	1.05	0.84	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	5.72	2.63	3.40	2.01	0.77	0.31	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	1.08	3.23	7.55	4.31	1.08	1.08	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	7.47	4.48	2.69	3.59	0.00	0.90	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	4.44	1.02	1.02	1.71	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	19.48	4.40	8.64	5.10	0.63	0.24	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.72	12.18	7.15	7.95	1.61	0.50	2.92	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.61	15.02	10.24	8.19	1.59	0.46	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	5.43	3.02	1.81	4.83	0.00	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	14.57	15.37	6.62	6.89	1.32	0.00	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	15.05	7.32	7.72	8.39	0.80	0.40	0.27	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	13.02	9.27	5.63	6.89	1.00	0.25	0.38	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	6.85	8.37	2.54	7.36	1.27	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.40	8.44	4.67	7.09	1.51	0.60	0.45	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	0.75	1.50	2.25	0.75	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	6.46	6.46	1.29	1.29	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	10.70	3.72	5.12	2.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	11.11	16.16	7.07	7.07	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	6.27	9.72	4.39	3.13	0.94	0.31	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	4.42	0.59	1.77	1.77	0.00	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.74	16.33	8.08	11.41	0.50	0.50	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	7.94	4.67	2.80	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.46	4.75	3.31	3.31	1.15	0.72	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	5.10	6.63	3.31	4.84	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.88	3.20	2.07	2.44	0.19	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.84	10.06	9.36	8.66	0.98	0.14	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.52	15.08	10.31	7.37	0.92	0.42	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	4.76	1.43	3.33	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.65	5.63	1.96	2.69	0.00	0.24	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	10.83	9.28	3.76	6.63	1.77	0.44	0.22	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	6.73	8.78	2.63	7.61	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.22	2.53	4.86	3.69	0.58	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.52	3.44	4.76	3.97	0.53	0.00	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	13.02	7.07	6.70	2.23	0.74	0.37	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.37	5.03	7.19	4.31	0.36	0.72	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	8.52	3.41	4.26	3.97	0.28	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.42	2.36	2.36	3.94	0.79	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	9.65	4.83	3.05	5.08	0.76	0.25	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	5.99	2.40	6.39	0.80	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	6.27	2.51	2.09	2.93	1.25	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	10.08	2.75	3.21	4.13	0.46	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	14.14	13.80	5.22	8.25	2.02	0.67	0.50	0.00
Synoviocyte, donor2	11368-117I9	17.43	10.23	7.71	5.36	1.01	1.01	0.84	0.00
Synoviocyte, donor3	11440-118H9	12.73	6.26	2.68	5.81	0.45	0.45	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	9.29	3.57	3.57	3.57	0.36	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	1.98	3.96	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.02	4.86	3.24	3.01	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	13.12	4.30	6.59	4.09	0.79	0.14	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	3.48	1.93	2.71	1.93	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	4.58	2.86	1.15	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	39.12	11.07	17.72	8.73	1.11	0.98	0.12	0.00
Urethra, donor2	10319-105A4	64.74	1.80	19.78	5.40	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	5.84	2.13	3.98	1.86	0.00	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	6.41	0.80	2.40	0.00	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.81	1.38	2.52	0.69	0.00	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	21.62	9.58	14.27	6.24	1.56	0.45	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	64.95	12.46	46.27	19.58	3.56	7.12	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	60.04	7.15	67.19	22.87	1.43	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.97	6.16	40.39	10.27	0.00	4.79	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.09	8.61	20.66	8.26	0.34	2.07	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	33.70	6.39	20.34	13.36	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	60.39	15.62	44.77	10.41	0.00	8.33	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	61.49	6.42	64.25	16.52	0.00	7.34	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	7.30	32.86	9.13	3.65	6.39	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	12.46	9.99	3.58	7.28	1.60	0.25	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	100.32	7.92	17.60	3.52	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.30	4.19	5.31	0.84	0.28	1.68	0.00	0.28
achilles tendon, donor2	10292-104G4	39.26	24.80	12.40	6.20	4.13	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	16.83	4.84	7.14	3.82	1.27	0.25	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	15.79	6.73	4.64	4.88	0.46	0.70	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	15.55	6.29	7.72	3.68	0.95	0.36	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	19.05	12.79	4.08	10.07	2.18	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	17.71	10.40	7.59	15.18	0.56	0.56	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	10.36	10.15	5.92	13.96	2.54	0.63	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	5.99	7.08	3.27	8.44	0.54	0.27	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	13.22	8.37	3.97	7.05	1.32	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	5.72	7.76	2.04	9.80	0.41	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	10.10	8.54	3.49	9.32	0.78	0.78	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	6.62	7.36	2.21	11.41	2.02	0.18	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	19.50	19.50	0.00	0.00	0.00	0.00	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	5.11	13.25	0.93	10.46	1.16	0.00	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	21.23	2.59	3.88	4.66	0.00	0.78	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	10.81	4.09	4.09	6.72	0.88	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	10.69	11.62	6.04	9.76	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	13.57	6.17	3.70	12.34	0.82	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	6.14	2.46	2.76	4.91	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.52	8.11	3.41	11.52	1.71	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	9.10	6.37	3.64	8.80	0.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	11.31	8.91	4.09	8.67	0.24	0.96	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	5.57	6.46	1.78	8.46	1.11	0.45	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	19.68	5.67	7.34	4.00	0.67	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	66.90	13.01	13.01	3.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	7.16	14.69	1.13	10.55	1.13	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	18.32	6.11	4.80	6.98	0.87	1.31	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	7.50	16.87	7.50	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	15.78	15.54	6.36	3.77	1.88	0.71	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	24.66	8.84	9.93	6.36	1.71	1.09	2.64	0.00
adipose, donor1	10184-103D4	117.28	5.28	36.36	2.35	0.59	1.17	0.59	0.00
adipose, donor2	10185-103D5	27.98	5.68	8.52	2.43	0.81	0.81	1.22	0.00
adipose, donor3	10186-103D6	25.32	2.45	8.17	3.00	0.54	1.36	1.09	0.00
adipose, donor4	10187-103D7	44.20	8.67	17.34	6.07	0.00	0.87	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	14.84	3.31	1.89	3.63	0.32	0.32	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	7.28	10.91	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	25.08	12.41	13.47	10.01	1.07	0.93	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	13.58	6.07	2.86	3.57	0.00	0.36	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	25.74	23.42	9.51	12.52	2.55	0.93	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	19.61	14.88	8.79	7.78	2.37	0.34	1.01	0.00
amniotic membrane cells, donor3	12237-129G5	46.25	15.02	11.78	8.54	0.29	1.18	0.00	0.29
amygdala - adult, donor10196	10167-103B5	52.18	16.60	22.53	15.42	3.56	1.19	1.19	1.19
amygdala, adult, donor10252	10151-102I7	85.97	21.29	40.55	6.89	3.24	2.64	0.41	0.00
amygdala, newborn, donor10223	10360-105E9	29.05	8.71	9.04	6.46	3.23	0.32	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	25.21	6.75	11.84	6.11	0.76	0.51	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	9.71	13.02	7.28	5.29	0.88	0.88	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	28.39	5.01	11.36	2.00	0.00	2.34	0.00	0.00
aorta, adult, pool1	10052-101G7	20.40	12.16	8.04	5.69	0.59	2.55	0.39	0.00
appendix, adult	10189-103D9	41.14	7.37	21.35	3.49	1.16	0.39	0.78	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.08	5.16	11.69	4.13	1.03	0.00	0.34	0.00
artery, adult	10190-103E1	32.61	0.00	12.23	1.36	0.00	2.72	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	24.34	7.68	11.30	7.97	1.01	0.43	0.29	0.00
b cell line:RPMI1788	10427-106D4	28.85	6.69	12.34	8.92	0.30	0.89	0.15	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	13.59	20.53	4.72	9.99	3.88	0.00	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	16.08	9.03	8.34	4.27	1.39	0.40	0.00	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	58.75	8.54	16.24	4.18	1.17	1.51	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	11.18	10.63	5.59	6.15	0.00	2.24	0.00	0.56
bladder, adult, pool1	10011-101C2	48.24	5.21	15.86	4.67	0.87	1.30	0.76	0.00
blood, adult, pool1	10053-101G8	17.72	8.86	11.07	2.21	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	15.41	16.27	3.43	6.85	4.28	0.00	0.00	0.00
bone marrow, adult	10192-103E3	14.85	5.40	8.10	8.77	2.70	0.67	0.67	0.00
brain, adult, donor1	10084-102B3	39.98	5.13	11.28	7.18	0.00	1.03	1.03	0.00
brain, adult, pool1	10012-101C3	80.62	12.36	28.51	9.91	2.90	1.11	1.00	0.33
brain, fetal, pool1	10085-102B4	21.37	10.69	8.01	5.34	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	106.38	7.93	34.03	3.30	2.31	0.99	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	30.08	6.24	6.87	7.24	1.12	1.50	0.12	0.00
breast, adult, donor1	10080-102A8	15.15	7.58	2.53	2.53	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	11.05	4.95	5.72	9.53	0.89	0.51	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.48	13.91	7.73	8.35	1.55	2.16	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	11.74	20.03	6.91	14.73	1.84	1.15	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	19.85	14.77	7.99	12.35	1.69	0.97	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	26.33	2.82	8.46	0.47	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	24.94	7.88	10.28	3.50	1.64	0.77	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	20.60	4.75	7.92	3.49	0.32	0.63	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	27.42	3.99	8.25	4.26	1.33	0.27	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	63.32	16.12	12.66	13.82	3.45	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	72.45	22.59	20.75	9.87	0.67	1.17	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	36.68	6.88	1.53	18.34	1.53	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	38.45	3.66	8.79	6.96	2.20	0.37	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	52.44	20.39	26.22	5.83	2.91	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	76.01	20.50	46.76	6.19	1.71	2.35	0.21	0.00
cerebellum, adult, pool1	10083-102B2	28.98	6.55	12.42	4.14	1.72	1.03	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	68.08	2.49	29.06	2.49	0.83	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	73.12	13.87	28.74	8.07	1.76	2.02	1.26	0.25
cerebrospinal fluid, donor2	10294-104G6	30.70	5.85	8.77	2.92	0.73	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	21.57	2.59	5.18	2.30	0.14	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	17.23	12.76	8.78	5.63	1.66	0.99	0.33	0.00
cervix, adult, pool1	10013-101C4	40.11	9.76	12.81	6.93	1.36	0.84	0.94	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	45.42	5.71	19.09	5.16	1.67	0.42	0.14	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	62.70	0.00	16.98	0.00	0.00	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	32.44	4.60	14.79	3.60	0.99	1.37	0.50	0.00
choriocarcinoma cell line:SCH	10785-110H2	79.10	13.31	29.32	8.26	0.99	0.99	0.62	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	27.28	3.32	19.69	2.13	0.00	0.24	0.24	0.24
chorionic membrane cells, donor1	12238-129G6	22.22	18.80	10.54	11.11	1.71	0.85	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	16.01	26.65	10.24	9.94	2.29	1.09	0.99	0.10
chorionic membrane cells, donor3	12240-129G8	30.77	17.03	20.33	14.84	2.20	4.95	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	5.05	12.12	1.01	2.02	0.00	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	13.83	4.99	4.61	4.23	0.58	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	10.35	9.93	5.28	8.03	0.63	0.42	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	41.34	9.76	10.79	4.11	1.28	1.80	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	37.01	8.22	10.40	6.77	1.21	1.45	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	41.13	9.16	12.42	5.29	1.02	2.04	0.00	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	30.92	8.83	8.24	2.94	1.77	0.59	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	19.55	5.47	13.55	6.52	1.30	0.26	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.89	5.71	4.34	5.71	0.46	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	10.76	5.38	4.34	3.30	0.52	0.35	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	14.46	20.13	6.96	6.96	2.38	1.10	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	34.21	7.60	10.64	3.04	0.38	0.38	0.00	0.00
colon, adult, donor1	10082-102B1	10.71	4.76	1.19	1.19	1.19	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	40.19	6.93	14.69	5.64	0.94	1.53	1.29	0.12
colon, fetal, donor1	10070-101I7	34.61	8.03	9.27	10.51	3.09	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	91.67	4.58	9.17	9.17	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	25.50	12.75	15.72	10.20	0.85	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	13.89	7.24	8.00	6.04	0.60	0.30	2.41	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	10.86	9.87	6.63	6.20	0.85	0.28	0.28	0.14
corpus callosum, adult, pool1	10042-101F6	83.47	9.95	25.32	5.97	1.11	0.44	0.11	0.22
cruciate ligament, donor2	10295-104G7	49.44	10.54	17.83	4.05	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	19.26	9.63	4.82	8.03	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	70.56	8.88	22.80	6.48	2.16	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	10.56	4.59	5.28	2.30	1.38	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	34.88	6.41	14.87	7.95	1.03	0.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.15	11.55	3.85	1.93	1.20	0.00	0.48	0.24
ductus deferens, adult	10196-103E7	31.40	8.47	10.96	14.95	1.00	1.00	0.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	27.36	2.88	10.08	5.76	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	5.15	20.60	6.62	1.47	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	32.95	14.45	13.30	11.31	0.99	1.16	0.41	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.77	11.77	7.55	3.11	1.11	1.78	2.89	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	8.17	4.73	3.30	1.86	0.86	0.43	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	89.41	4.93	28.36	3.70	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	33.30	9.99	10.90	5.15	0.91	0.30	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	81.20	7.10	20.69	3.70	0.62	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	132.66	15.76	31.52	9.19	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	46.93	10.39	18.77	9.05	1.68	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	30.09	4.53	10.15	9.97	0.91	0.91	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	21.71	7.56	6.91	3.38	0.80	0.32	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	18.79	4.45	8.34	2.33	0.44	0.22	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	12.10	7.04	4.73	4.07	0.66	0.55	0.11	0.00
epididymis, adult	10197-103E8	31.61	9.00	15.28	9.00	1.26	0.63	0.21	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	25.72	10.11	6.92	10.47	1.42	0.35	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	11.01	5.90	3.93	3.93	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	21.23	13.63	7.86	5.24	1.05	0.13	0.00	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	23.52	15.26	10.92	5.81	1.67	1.08	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	19.72	19.05	6.50	6.27	1.23	0.56	0.00	0.11
esophagus, adult, pool1	10015-101C6	31.96	14.02	10.09	7.86	1.91	1.38	1.38	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	43.96	4.88	9.77	4.51	0.38	0.00	0.00	0.00
eye - muscle inferior rectus, donor1	10272-104E2	77.27	2.41	19.32	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	39.98	8.42	2.10	0.00	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	55.06	1.49	14.88	0.00	0.00	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	41.27	2.29	6.88	1.15	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	27.69	20.40	10.20	5.83	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	38.64	7.63	6.36	7.12	0.25	0.76	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	14.75	9.23	4.62	6.92	0.38	0.51	0.64	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	27.54	8.31	10.21	7.60	0.71	0.71	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	78.44	14.17	28.43	10.79	4.32	1.78	0.38	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.25	7.21	20.42	3.00	0.90	1.20	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.68	3.38	12.07	3.38	0.73	0.27	0.09	0.09
gall bladder, adult	10198-103E9	47.32	5.79	15.45	4.35	0.72	0.97	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	12.88	6.98	10.74	3.22	1.07	1.07	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	17.18	5.98	14.19	4.48	1.49	1.49	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	24.92	9.08	9.93	5.28	1.48	0.63	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.00	12.57	23.60	5.03	1.74	0.19	0.39	0.00
gastric cancer cell line:AZ521	10549-107H9	28.20	10.17	14.10	7.87	1.48	0.33	0.00	0.16
gastric cancer cell line:GSS	10560-108A2	31.12	6.41	2.75	4.58	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.07	5.25	8.68	1.60	0.91	0.46	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	23.06	1.61	8.26	0.69	0.11	0.23	0.23	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	22.11	17.35	10.22	8.96	1.54	0.42	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	42.65	5.74	20.70	10.72	1.50	1.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	22.17	7.39	4.86	6.76	1.37	0.63	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	25.00	10.95	6.88	9.83	1.12	0.84	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	8.61	15.12	2.21	7.62	1.21	0.44	0.00	0.11
glioma cell line:GI-1	10413-106B8	19.92	4.39	6.44	3.22	0.00	0.00	0.59	0.00
globus pallidus - adult, donor10196	10175-103C4	56.86	10.93	13.85	13.12	2.19	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	104.47	21.48	36.37	8.30	2.20	2.44	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	52.03	4.11	12.32	10.95	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.30	5.33	11.72	2.66	0.53	2.13	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	39.15	14.68	9.79	9.79	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	5.23	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	21.44	10.88	9.60	5.44	0.96	0.64	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	35.81	16.07	7.80	7.80	1.38	2.30	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	24.69	12.35	5.94	3.20	0.46	0.91	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	19.97	14.81	2.58	2.58	0.00	1.93	0.64	0.00
hIPS, biol_rep1	14380-156B6	33.06	8.62	4.31	2.87	4.31	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	28.12	11.66	3.43	4.80	0.00	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	51.86	5.52	11.03	13.24	5.52	1.10	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	9.77	3.74	6.90	4.88	0.57	1.15	0.00	0.00
heart - mitral valve, adult	10205-103F7	55.61	4.48	18.83	6.28	2.09	0.00	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	46.54	7.06	16.73	4.71	0.52	1.05	0.26	0.26
heart - tricuspid valve, adult	10207-103F9	49.13	7.49	22.48	5.83	0.00	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	19.79	7.14	7.75	1.63	1.63	0.61	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	19.16	4.26	5.54	2.13	0.85	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	60.94	5.06	21.85	5.75	0.92	0.46	0.00	0.00
heart, fetal, pool1	10046-101G1	51.03	8.11	16.02	5.65	0.62	0.72	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.83	11.11	11.11	8.95	0.93	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	98.70	4.76	29.73	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	22.87	10.28	9.50	2.65	1.66	0.44	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	22.33	11.53	9.83	2.31	1.70	0.49	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	27.28	10.41	8.59	2.63	1.62	0.71	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	22.24	4.67	9.23	2.00	0.44	0.33	0.11	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	9.35	6.33	3.72	2.91	0.60	1.71	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	67.19	17.03	22.71	10.41	2.84	3.79	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	75.52	21.02	39.39	6.74	2.45	1.43	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	47.80	11.45	8.47	5.98	3.49	0.00	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	30.67	6.70	7.05	5.99	1.76	0.35	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	70.19	7.32	26.24	3.66	1.22	0.61	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	38.68	5.69	14.33	3.14	0.20	0.39	0.59	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.64	5.59	12.95	3.81	0.51	1.02	0.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	27.63	1.13	12.41	1.13	0.00	0.00	1.69	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	32.02	2.32	13.17	1.81	0.00	0.00	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	37.96	1.14	14.05	3.04	0.38	0.76	2.28	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	31.53	3.21	7.01	1.75	0.00	0.29	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	34.90	3.66	8.62	3.88	0.65	0.00	1.72	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	26.69	2.50	6.26	1.67	1.25	0.83	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	21.31	3.79	8.76	3.08	0.24	0.00	0.47	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	21.21	2.09	5.46	1.61	0.32	0.48	0.80	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.83	4.04	5.39	1.35	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	32.24	6.10	16.43	2.66	0.78	0.78	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.00	8.84	13.76	2.46	0.98	1.47	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	42.76	4.36	16.58	3.49	2.62	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	28.25	3.25	12.79	1.72	0.57	0.38	2.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	25.29	2.62	13.08	2.62	0.00	0.00	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	34.98	4.00	12.99	4.00	0.00	1.00	3.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.74	4.71	10.17	1.70	0.19	0.00	1.13	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	4.55	8.18	4.55	0.00	0.45	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	28.82	3.13	10.34	3.13	0.94	0.31	1.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	19.60	3.92	9.14	2.61	0.65	0.82	0.16	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	18.29	2.90	5.81	2.61	0.87	0.58	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	19.13	2.69	6.88	2.69	1.20	0.30	0.90	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	29.56	9.42	14.96	2.96	2.03	0.55	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	27.67	9.41	10.56	4.85	0.86	0.29	1.71	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	8.98	15.92	5.72	1.22	1.22	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.29	4.58	7.75	1.41	0.70	0.70	2.11	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	15.84	2.85	4.75	1.27	0.32	0.32	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	19.67	2.72	4.54	1.82	0.30	0.00	1.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	17.07	5.17	4.65	2.07	0.52	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	15.28	2.66	5.98	0.66	2.66	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	20.27	2.31	4.62	2.05	0.51	0.26	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	13.04	6.65	4.35	3.07	0.77	0.26	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	13.63	7.57	9.09	3.79	1.51	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	20.16	3.36	5.38	3.02	1.68	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.02	9.66	11.11	4.35	0.97	0.48	0.24	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	43.23	4.01	14.71	4.01	1.78	0.45	1.34	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	37.07	5.85	9.27	3.90	1.46	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	26.28	4.28	7.03	1.22	0.61	0.61	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	165.92	6.51	74.82	6.51	3.25	0.00	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.12	3.31	12.24	1.65	1.99	0.99	2.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	24.08	4.38	3.28	2.19	0.55	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	24.97	1.81	6.51	2.53	0.36	1.09	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.06	2.85	9.25	1.78	0.36	0.36	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	0.00	7.16	2.39	1.19	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	23.29	3.93	6.23	2.71	1.08	0.41	0.95	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	16.16	3.77	5.39	1.35	1.08	0.54	0.27	0.00
immature langerhans cells, donor1	11904-125F5	4.84	75.07	3.39	33.90	10.41	0.97	1.70	1.70
immature langerhans cells, donor2	11905-125F6	21.39	50.70	7.13	17.43	6.34	2.38	0.00	1.58
insula, adult, pool1	10039-101F3	66.05	12.87	26.31	10.41	4.16	1.89	0.76	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	2.93	9.10	3.25	4.23	0.98	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	32.34	12.02	14.42	7.41	1.70	1.50	0.90	0.30
kidney, fetal, pool1	10045-101F9	34.94	7.14	12.03	4.46	0.85	0.78	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	29.68	16.33	12.36	5.11	1.42	1.56	0.99	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	8.16	2.49	6.22	2.35	0.55	0.14	0.14	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	73.03	8.44	26.61	3.30	1.65	0.92	0.18	0.00
left atrium, adult, donor1	10079-102A7	14.71	8.72	8.72	5.45	1.09	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	30.34	7.08	10.62	3.03	1.52	0.51	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	15.32	5.47	5.20	3.56	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	8.26	5.39	3.23	5.03	0.00	0.36	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	5.43	10.33	6.52	4.89	1.63	0.54	0.54	0.00
leiomyoma cell line:15425	10571-108B4	11.90	8.50	3.64	8.50	1.94	0.49	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	0.00	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	3.14	7.32	1.05	0.00	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	12.04	13.10	11.33	7.08	1.18	0.47	0.47	0.00
liposarcoma cell line:KMLS-1	10782-110G8	9.69	12.34	4.84	6.56	0.94	0.31	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	10.97	8.53	4.87	5.36	0.85	0.24	0.00	0.00
liver, adult, pool1	10018-101C9	29.98	17.34	13.45	4.54	2.11	1.13	0.49	0.16
liver, fetal, pool1	10086-102B5	10.35	5.64	1.88	0.00	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	83.85	13.12	40.54	5.83	0.87	1.75	0.73	0.15
locus coeruleus, adult, donor10252	10165-103B3	85.08	16.98	38.94	6.64	2.95	3.14	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	22.01	5.08	8.18	5.08	0.85	0.85	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	46.69	6.73	14.72	6.73	1.26	1.68	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	30.72	11.49	18.54	5.54	1.25	0.69	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	10.34	6.20	8.27	1.38	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	7.12	14.76	3.69	12.39	2.24	3.69	0.26	0.00
lung, adult, pool1	10019-101D1	41.34	12.76	21.62	6.85	1.42	1.89	0.83	0.00
lung, fetal, donor1	10068-101I5	106.17	18.84	51.37	23.40	3.71	2.57	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	24.74	10.54	6.87	5.04	0.46	1.37	1.83	0.00
lymph node, adult, donor1	10077-102A5	15.62	12.31	8.99	5.21	1.42	0.95	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	16.44	4.38	8.11	4.38	0.66	0.22	0.00	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.74	5.58	2.57	2.11	0.30	0.15	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	64.56	7.65	28.88	5.10	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	38.18	17.76	8.44	8.44	1.78	0.00	0.89	0.00
mature adipocyte, donor2	12232-129F9	36.32	20.75	14.11	4.57	1.66	0.42	0.21	0.00
mature adipocyte, donor3	12233-129G1	37.69	20.62	10.43	7.35	0.95	0.71	1.42	0.00
mature adipocyte, donor4	12234-129G2	33.43	21.06	14.48	7.90	1.58	0.53	1.05	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	47.41	6.67	20.73	4.53	0.48	0.48	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	15.79	21.43	16.92	3.38	3.38	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	84.60	16.74	39.17	8.09	2.94	2.02	0.18	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	33.36	4.77	13.66	4.13	1.91	2.22	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	82.31	11.09	30.28	7.68	4.69	1.28	0.85	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	53.83	15.69	32.74	10.97	4.39	2.53	0.34	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	94.44	18.68	53.06	8.28	4.67	1.91	0.00	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	9.63	3.85	3.85	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	28.71	86.12	28.71	14.35	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	37.69	10.05	16.87	6.46	4.31	1.44	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	55.81	14.93	20.12	7.14	0.65	0.65	0.00	1.30
medulla oblongata, adult, donor10252	10155-103A2	70.75	15.17	27.40	6.50	1.24	1.55	0.15	0.46
medulla oblongata, adult, pool1	10038-101F2	71.34	9.22	31.43	6.69	2.69	1.22	0.16	0.24
medulla oblongata, newborn, donor10223	10361-105F1	35.76	3.47	12.15	2.78	2.43	0.69	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	28.34	6.86	8.19	4.43	0.89	1.11	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	19.44	7.09	5.38	4.04	0.61	0.61	0.00	0.12
melanoma cell line:COLO 679	10514-107E1	12.36	8.62	9.92	5.46	1.15	0.14	0.72	0.00
melanoma cell line:G-361	10465-106H6	15.47	8.14	13.30	4.61	0.81	0.27	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	16.46	5.07	7.96	3.26	0.18	0.18	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	41.41	2.64	13.22	3.52	0.00	0.88	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	37.07	2.07	8.30	2.85	0.00	0.00	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	9.51	18.41	5.83	12.74	0.92	0.61	0.46	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.36	11.45	7.63	8.54	1.27	0.73	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	9.52	4.56	1.24	3.73	0.41	0.83	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.68	10.11	3.37	6.46	0.70	1.12	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	9.24	9.63	4.62	7.32	0.39	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	5.55	3.47	3.47	0.69	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.85	5.84	10.81	4.29	1.20	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.38	7.13	5.29	4.49	0.35	0.12	0.00	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	12.87	10.08	6.50	8.22	1.46	0.40	0.13	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	12.83	15.12	6.21	9.99	0.54	0.41	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	15.65	15.79	10.81	11.67	1.42	0.43	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.43	5.93	9.88	7.90	0.99	0.99	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.01	16.05	7.47	13.70	1.11	0.42	0.14	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	5.59	8.03	3.84	10.12	2.09	0.70	1.05	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	16.54	11.43	6.94	7.76	1.02	1.02	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	9.71	7.19	9.71	2.52	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	17.38	7.55	4.34	6.00	0.62	0.21	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.44	7.07	7.52	4.33	1.82	0.91	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	16.36	12.59	7.55	13.85	1.26	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.46	14.50	5.08	10.46	1.20	1.64	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	15.49	14.97	8.23	7.44	1.84	0.35	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	14.73	7.00	5.15	7.73	0.74	0.74	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	9.44	9.73	5.44	6.01	1.72	0.29	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.95	8.84	5.89	6.74	1.68	0.84	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	13.24	7.76	3.65	5.48	0.46	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	11.51	6.14	5.88	7.16	0.51	0.51	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.40	7.33	4.97	4.19	0.00	0.52	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.78	4.62	2.16	6.78	0.92	0.62	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	11.30	7.30	2.82	6.59	0.94	0.47	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	7.78	4.06	7.45	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	10.61	11.00	2.75	6.29	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.88	2.78	5.10	5.56	1.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.71	9.81	6.63	11.25	1.15	0.00	0.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.04	6.47	5.13	7.81	0.45	0.00	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	11.30	8.17	3.61	8.41	0.72	0.96	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	22.00	5.87	2.93	3.67	0.73	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.06	3.36	2.35	7.05	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	13.10	6.96	2.05	4.50	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.45	4.73	4.73	6.01	0.43	0.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	2.73	5.47	2.73	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	10.33	5.16	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.17	2.27	1.30	7.47	0.97	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	1.45	5.82	2.91	7.27	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	4.26	3.73	0.00	5.86	0.53	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.00	4.91	2.45	5.72	2.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	4.28	7.77	1.55	8.16	0.00	0.00	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	6.30	2.10	6.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	1.99	2.98	3.97	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00	0.00	4.77	4.77	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	4.74	2.96	8.89	0.59	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	2.44	2.44	1.22	1.22	1.22	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	6.33	5.07	3.17	5.07	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	5.17	2.41	6.55	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	2.15	4.30	0.00	4.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	3.99	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	10.33	3.44	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	5.70	6.93	2.04	4.48	0.81	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	9.53	5.56	3.18	3.97	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	8.25	2.95	1.77	5.90	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	6.86	4.99	3.74	5.61	0.00	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	4.01	2.67	6.68	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	2.37	8.28	1.18	5.91	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	5.14	7.70	5.14	12.84	0.00	0.00	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	6.20	6.88	4.13	4.82	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	14.35	4.45	5.94	3.96	1.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	6.73	3.36	2.24	0.00	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	5.09	1.91	1.91	6.36	0.64	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	5.24	5.64	3.22	1.21	0.40	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	2.18	8.72	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	5.07	5.07	0.00	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	18.21	7.28	12.74	4.86	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	4.52	0.00	9.04	0.00	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	10.71	7.41	7.41	4.12	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	4.56	3.57	1.59	4.96	0.79	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.41	6.17	2.27	3.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	3.06	2.04	3.06	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.80	7.74	5.42	4.64	1.55	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	92.13	11.10	15.12	6.85	0.71	0.47	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	38.23	34.52	21.31	21.31	2.55	1.39	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	4.27	4.27	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	4.11	9.66	2.26	2.06	1.13	0.41	0.10	0.10
mesothelioma cell line:Mero-25	10850-111F4	14.75	8.62	10.44	5.45	0.45	0.23	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	12.96	5.62	5.13	8.56	0.49	1.71	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	7.75	10.41	4.65	4.65	0.66	0.22	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	13.67	21.81	8.15	12.88	3.68	0.53	0.00	0.26
mesothelioma cell line:Mero-83	10854-111F8	13.62	11.23	6.47	7.66	1.70	0.85	0.68	0.00
mesothelioma cell line:Mero-84	10855-111F9	2.27	4.04	0.51	1.77	1.01	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	12.84	7.87	3.11	6.00	1.04	1.04	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	3.81	6.79	1.66	3.15	0.50	0.17	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	6.88	13.76	1.81	7.06	1.81	0.72	0.00	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	8.37	6.83	2.90	7.00	1.37	0.00	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	24.94	12.72	6.11	9.92	2.54	0.51	0.00	0.00
mesothelioma cell line:No36	10857-111G2	16.31	5.22	1.63	3.59	0.33	0.00	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	5.42	4.88	1.90	2.17	0.27	1.35	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	15.16	5.57	8.44	3.84	0.58	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	13.07	4.27	5.25	3.91	0.49	0.00	0.00	0.12
migratory langerhans cells, donor3	11903-125F4	9.87	7.36	6.46	8.26	1.26	0.90	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	53.54	5.55	16.32	2.61	0.33	0.33	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	15.90	10.60	12.29	4.87	1.27	0.85	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	39.85	9.21	18.66	4.61	0.46	1.15	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	5.33	5.52	3.62	5.14	0.57	0.38	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	16.45	3.51	5.54	3.33	1.11	0.55	0.18	0.00
myeloma cell line:PCM6	10474-106I6	14.43	2.57	5.14	4.15	0.40	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	48.70	15.22	16.23	7.61	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	12.55	10.20	7.85	5.10	0.98	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	12.93	11.59	4.79	8.02	0.89	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	16.47	9.05	5.59	6.25	0.37	0.51	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	11.59	17.11	4.42	6.62	1.66	0.00	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	48.31	7.59	20.71	5.75	1.61	1.15	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	75.02	6.92	18.15	5.43	1.12	0.19	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	28.05	5.90	13.29	2.74	0.42	0.00	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	51.43	5.22	12.11	0.93	1.12	0.00	0.56	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	33.21	2.14	3.32	1.19	0.47	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	17.42	8.08	9.03	4.59	0.95	0.95	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	21.33	4.63	5.23	2.62	0.40	0.60	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	34.33	1.27	3.81	0.64	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	15.44	8.52	7.19	7.45	0.53	0.80	0.00	0.00
neutrophil PMN, donor1	12133-128D9	312.37	0.00	59.50	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	13.28	13.28	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	47.35	0.00	28.41	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	33.49	26.89	15.56	19.79	1.69	1.52	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	12.01	3.20	4.00	2.40	0.00	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	16.67	7.05	5.45	8.98	1.28	0.96	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	11.04	11.04	7.09	4.73	0.79	0.26	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	67.30	14.25	24.56	9.28	2.25	1.87	0.28	0.00
occipital cortex - adult, donor10196	10172-103C1	82.42	20.60	30.91	2.06	2.06	8.24	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	98.22	19.86	48.31	8.05	1.88	2.15	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	39.67	8.01	19.65	8.73	3.64	0.36	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	45.40	10.23	19.42	9.45	1.31	2.36	1.84	0.00
occipital lobe, fetal, donor1	10073-102A1	42.91	10.73	5.58	7.72	2.15	0.00	1.29	0.00
occipital pole, adult, pool1	10036-101E9	42.42	5.12	14.59	5.52	1.73	1.42	0.16	0.08
olfactory region, adult	10195-103E6	68.78	13.76	26.75	7.26	2.29	1.53	0.38	0.00
optic nerve, donor1	10277-104E7	128.07	6.00	20.01	4.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.93	6.04	7.40	3.53	0.91	0.23	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.90	4.40	8.52	1.24	0.55	0.00	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.92	5.93	6.10	4.23	1.19	0.34	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.10	18.60	9.36	9.82	1.50	0.46	0.35	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	18.81	5.29	7.06	5.29	0.59	0.88	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	64.47	5.61	13.08	4.67	0.00	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	14.00	8.06	8.48	5.94	1.48	0.85	0.21	0.00
ovary, adult, pool1	10020-101D2	36.51	3.93	10.48	2.62	0.35	0.44	0.00	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	16.13	4.40	5.50	3.85	0.18	0.73	0.00	0.00
pancreas, adult, donor1	10049-101G4	40.45	10.35	14.11	1.88	2.82	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.15	8.39	23.48	6.15	1.12	2.24	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	14.99	13.12	9.54	6.47	0.85	0.34	0.34	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	25.00	8.78	12.25	5.30	0.83	0.66	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	72.49	10.71	29.10	9.79	2.56	1.56	0.46	0.09
parietal cortex, adult, donor10258	10373-105G4	45.51	11.01	5.14	13.95	0.73	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	63.95	9.40	31.98	8.46	2.82	0.94	1.88	0.00
parietal lobe, adult, donor10252	10157-103A4	90.36	17.39	42.19	5.70	1.43	3.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	66.35	8.72	23.97	7.84	2.20	1.15	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	51.40	9.70	17.46	9.70	1.94	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	47.85	8.60	14.21	10.09	4.11	0.75	0.75	0.75
parotid gland, adult	10199-103F1	27.75	11.10	11.10	11.10	0.00	3.08	0.00	0.00
penis, adult	10200-103F2	27.39	4.83	10.74	3.76	0.54	0.54	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.01	3.72	1.30	3.16	0.56	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	12.68	9.32	5.25	6.26	1.02	1.17	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	99.33	7.10	38.70	12.90	0.65	1.94	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	106.01	24.87	31.39	11.25	2.96	5.92	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	45.15	10.03	18.19	7.52	3.76	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	77.91	6.07	21.25	2.02	0.00	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	103.71	11.47	42.74	4.69	3.13	1.04	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	27.24	8.51	9.36	4.26	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	55.47	13.22	19.46	13.76	2.37	4.09	0.54	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	8.74	2.91	6.62	2.25	0.13	0.26	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	15.88	4.98	7.00	2.49	0.00	0.00	0.00	0.16
pons, adult, pool1	10033-101E6	73.33	12.91	34.25	7.32	2.84	2.32	0.17	0.17
postcentral gyrus, adult, pool1	10032-101E5	50.13	7.32	22.23	6.45	2.18	1.74	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	58.56	18.82	14.64	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	5.51	5.51	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	10.49	11.07	5.54	5.83	1.02	0.29	0.58	0.00
prostate cancer cell line:PC-3	10439-106E7	39.93	23.78	20.87	18.33	2.18	1.27	0.18	0.36
prostate, adult, pool1	10022-101D4	34.64	5.35	11.70	5.44	0.27	0.63	0.27	0.00
putamen, adult, donor10196	10176-103C5	77.43	28.56	29.04	16.29	2.60	1.42	0.24	0.24
putamen, adult, donor10252	10152-102I8	29.41	11.76	13.73	7.84	3.92	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	42.62	6.56	7.65	4.37	2.19	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	52.19	7.49	7.01	10.15	3.14	1.21	0.48	0.24
putamen, newborn, donor10223	10365-105F5	43.48	3.00	16.49	5.25	3.00	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	34.62	3.49	12.22	2.04	0.58	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	33.38	16.69	11.13	5.56	1.39	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	5.09	7.42	1.91	8.06	0.64	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.33	0.41	10.36	2.49	0.41	1.24	0.41	0.00
retina, adult, pool1	10030-101E3	41.25	8.75	15.21	5.77	1.19	0.99	0.30	0.00
retinoblastoma cell line:Y79	10475-106I7	28.06	4.42	7.01	3.38	1.04	0.00	0.52	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.72	8.85	7.75	4.79	0.98	0.25	0.12	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	57.08	7.31	15.18	5.34	0.28	0.56	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	54.57	7.58	18.19	1.52	0.00	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.46	10.04	7.45	7.77	0.97	1.13	0.49	0.00
salivary acinar cells, donor2	11772-123I8	13.77	11.57	6.61	13.77	0.69	0.69	1.24	0.14
salivary acinar cells, donor3	11773-123I9	50.98	13.24	25.82	6.62	0.66	1.32	0.00	0.00
salivary gland, adult, pool1	10093-102C3	30.31	10.87	10.87	12.58	2.29	2.29	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	30.18	2.70	9.27	3.12	0.59	0.25	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.51	4.11	9.64	3.17	0.59	0.71	0.12	0.00
seminal vesicle, adult	10201-103F3	38.09	11.64	19.05	14.28	1.59	0.53	1.59	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	41.78	28.67	10.45	13.36	3.40	2.43	0.73	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	11.32	5.79	3.27	3.77	0.25	0.50	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	11.04	5.02	3.01	6.02	2.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	19.21	4.57	13.43	3.36	0.67	0.13	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	18.24	7.85	14.70	3.87	0.77	0.55	0.11	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	11.87	19.10	4.64	10.19	2.58	0.77	0.13	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	94.34	3.55	19.15	2.13	0.00	1.42	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	47.62	3.60	10.91	3.36	0.36	0.60	0.48	0.12
skeletal muscle, fetal, donor1	10066-101I3	20.10	9.05	2.01	6.03	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	13.57	0.00	13.57	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	31.56	13.89	7.57	5.05	1.26	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	9.01	6.00	4.67	3.34	0.33	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	69.98	17.02	19.54	3.47	0.95	0.32	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	24.67	6.17	8.10	7.13	0.96	0.39	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	16.98	15.49	11.21	8.90	1.48	2.47	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	54.37	3.22	19.78	2.25	0.00	0.80	0.48	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	54.48	14.38	24.19	9.15	2.40	1.09	0.22	0.22
small intestine, adult, pool1	10024-101D6	57.33	8.84	19.59	5.37	1.19	1.91	0.48	0.00
small intestine, fetal, donor1	10064-101I1	27.52	11.06	9.58	4.91	0.98	1.23	0.25	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	20.00	8.72	5.13	3.08	3.08	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	33.86	5.43	10.86	4.65	0.78	1.03	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	35.65	8.04	17.15	1.61	0.00	1.07	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	70.43	11.93	28.45	9.41	2.29	1.61	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	81.61	16.95	42.98	9.46	1.58	3.15	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	70.56	7.61	17.99	6.92	0.69	1.38	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	69.52	10.98	25.61	5.49	4.27	1.22	3.05	0.61
spinal cord, newborn, donor10223	10359-105E8	73.93	5.05	22.96	6.89	0.46	1.84	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	31.36	8.51	11.35	7.62	1.05	0.60	0.15	0.00
spleen, adult, pool1	10025-101D7	27.86	7.93	11.89	6.50	1.21	0.99	0.55	0.11
spleen, fetal, pool1	10044-101F8	26.86	10.49	10.33	5.32	1.03	1.59	0.48	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.52	5.18	4.97	6.21	0.52	0.21	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.03	9.49	17.28	4.75	1.14	0.38	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.26	7.34	5.59	4.19	2.10	1.05	0.35	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	34.40	5.86	20.33	5.86	0.78	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	20.71	3.49	7.65	3.04	0.34	0.45	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	5.51	3.81	1.27	3.39	0.85	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	8.04	13.12	3.81	6.35	0.42	1.27	0.00	0.00
stomach, fetal, donor1	10062-101H8	61.94	23.50	20.29	10.68	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	13.67	9.68	9.11	6.84	0.57	1.14	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	271.37	0.00	54.27	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	75.60	15.16	25.13	7.48	2.28	2.91	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	53.28	14.48	9.31	8.28	1.03	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.85	2.12	16.25	2.83	1.41	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	24.07	5.73	6.42	2.06	1.15	0.46	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	45.10	8.39	16.45	6.27	2.46	1.44	0.68	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	32.05	8.55	9.97	7.12	2.14	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.97	4.40	11.87	6.59	1.32	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	21.30	10.47	6.98	9.77	1.05	1.75	0.35	0.00
tenocyte, donor2	11765-123I1	13.35	9.92	7.63	4.96	0.76	2.29	0.00	0.00
tenocyte, donor3	11768-123I4	26.69	14.09	4.45	5.93	2.22	0.37	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	63.23	9.69	25.32	4.42	1.19	0.34	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	26.05	5.86	7.55	4.47	0.46	0.31	0.15	0.15
teratocarcinoma cell line:PA-1	10807-111A6	32.08	6.82	9.14	3.25	0.31	0.15	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	49.26	11.68	22.34	3.30	0.63	1.52	0.63	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	56.73	6.43	17.77	3.03	1.51	0.00	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.96	17.67	41.12	4.69	2.18	1.20	0.98	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	36.48	7.82	14.98	1.95	1.63	0.33	0.33	0.00
testis, adult, pool1	10026-101D8	38.98	7.73	12.88	3.87	0.54	0.54	0.86	0.11
testis, adult, pool2	10096-102C6	64.05	2.71	16.69	3.61	1.80	2.26	0.45	0.00
thalamus - adult, donor10196	10168-103B6	67.34	23.18	27.60	11.04	3.31	3.31	0.00	0.00
thalamus, adult, donor10252	10154-103A1	87.52	15.16	25.94	5.78	2.81	2.66	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	60.05	7.70	4.62	9.24	0.00	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.02	5.76	6.09	2.14	1.15	0.82	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	40.27	5.18	20.14	1.73	3.45	1.15	0.58	1.15
throat, adult	10209-103G2	26.96	5.74	9.99	7.74	0.75	0.50	0.50	0.25
throat, fetal, donor1	10061-101H7	36.56	13.10	13.10	5.18	1.83	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	9.34	5.17	4.37	4.17	1.39	0.60	0.00	0.00
thymus, adult, pool1	10027-101D9	57.66	7.16	14.42	4.08	0.60	0.50	0.50	0.20
thymus, fetal, pool1	10043-101F7	52.37	10.49	17.25	5.30	0.94	0.73	0.31	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	8.38	5.98	3.72	5.98	1.33	0.53	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	30.03	11.45	10.06	6.29	0.84	0.56	0.28	0.00
thyroid, adult, pool1	10028-101E1	41.15	8.40	15.68	8.58	1.40	1.49	0.84	0.28
thyroid, fetal, donor1	10060-101H6	41.40	10.81	12.92	8.70	0.26	1.58	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	83.15	9.24	46.19	6.16	3.08	3.08	0.00	0.00
tongue, adult	10203-103F5	29.07	11.86	14.65	9.30	1.63	1.16	0.47	0.00
tongue, fetal, donor1	10059-101H5	31.53	11.03	7.09	7.49	2.76	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	31.56	12.62	12.02	9.42	1.70	1.20	0.20	0.00
trachea, adult, pool1	10029-101E2	25.44	11.45	9.33	8.02	1.06	2.04	0.49	0.16
trachea, fetal, donor1	10058-101H4	30.01	15.77	14.23	6.16	1.54	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.82	3.90	7.09	7.79	0.35	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	11.96	5.47	10.74	5.07	0.30	0.30	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	54.06	11.12	13.48	4.07	0.94	0.63	0.16	0.16
tridermal teratoma cell line:HGRT	10694-109G1	68.49	3.81	13.32	3.81	0.00	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.53	18.54	6.18	5.25	2.20	0.42	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	27.12	10.43	6.26	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	48.97	4.44	13.14	7.34	1.02	1.37	0.17	0.00
uterus, fetal, donor1	10055-101H1	29.18	14.33	7.68	9.21	0.51	0.51	0.00	0.00
vagina, adult	10204-103F6	31.02	3.23	12.92	1.29	0.00	1.94	0.00	0.00
vein, adult	10191-103E2	23.45	5.48	8.77	3.73	1.32	0.66	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	12.28	7.21	1.87	3.20	0.80	0.80	0.27	0.00